CA2280814A1 - Stabilization sling for use in minimally invasive pelvic surgery - Google Patents
Stabilization sling for use in minimally invasive pelvic surgery Download PDFInfo
- Publication number
- CA2280814A1 CA2280814A1 CA002280814A CA2280814A CA2280814A1 CA 2280814 A1 CA2280814 A1 CA 2280814A1 CA 002280814 A CA002280814 A CA 002280814A CA 2280814 A CA2280814 A CA 2280814A CA 2280814 A1 CA2280814 A1 CA 2280814A1
- Authority
- CA
- Canada
- Prior art keywords
- sling
- suture
- site
- end portion
- suture receiving
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000001356 surgical procedure Methods 0.000 title claims abstract description 35
- 230000006641 stabilisation Effects 0.000 title claims description 23
- 238000011105 stabilization Methods 0.000 title claims description 23
- 239000000463 material Substances 0.000 claims abstract description 120
- 238000000034 method Methods 0.000 claims abstract description 55
- 239000000560 biocompatible material Substances 0.000 claims abstract description 53
- 206010046543 Urinary incontinence Diseases 0.000 claims abstract description 11
- 238000004519 manufacturing process Methods 0.000 claims abstract description 7
- 210000001519 tissue Anatomy 0.000 claims description 31
- 210000003708 urethra Anatomy 0.000 claims description 23
- 239000003381 stabilizer Substances 0.000 claims description 21
- 210000003689 pubic bone Anatomy 0.000 claims description 20
- 210000000988 bone and bone Anatomy 0.000 claims description 19
- 238000002513 implantation Methods 0.000 claims description 16
- 230000003014 reinforcing effect Effects 0.000 claims description 15
- 238000000576 coating method Methods 0.000 claims description 12
- 239000011248 coating agent Substances 0.000 claims description 11
- 230000000007 visual effect Effects 0.000 claims description 11
- 102000008186 Collagen Human genes 0.000 claims description 10
- 108010035532 Collagen Proteins 0.000 claims description 10
- 229920001436 collagen Polymers 0.000 claims description 10
- 230000002485 urinary effect Effects 0.000 claims description 10
- 239000003242 anti bacterial agent Substances 0.000 claims description 9
- 230000003115 biocidal effect Effects 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 6
- 230000000087 stabilizing effect Effects 0.000 claims description 6
- 108010001478 Bacitracin Proteins 0.000 claims description 4
- 229960003071 bacitracin Drugs 0.000 claims description 4
- 229930184125 bacitracin Natural products 0.000 claims description 4
- CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 claims description 4
- 238000004806 packaging method and process Methods 0.000 claims description 4
- 229930193140 Neomycin Natural products 0.000 claims description 3
- 229960004927 neomycin Drugs 0.000 claims description 3
- 238000005520 cutting process Methods 0.000 claims description 2
- 230000001954 sterilising effect Effects 0.000 claims description 2
- 238000005728 strengthening Methods 0.000 claims description 2
- 239000000725 suspension Substances 0.000 abstract description 4
- 229920000642 polymer Polymers 0.000 description 13
- 238000007789 sealing Methods 0.000 description 12
- 241000287107 Passer Species 0.000 description 11
- 210000003195 fascia Anatomy 0.000 description 11
- 239000000523 sample Substances 0.000 description 10
- 206010021639 Incontinence Diseases 0.000 description 9
- 238000013459 approach Methods 0.000 description 8
- 229920000728 polyester Polymers 0.000 description 7
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 206010052428 Wound Diseases 0.000 description 5
- 229940088710 antibiotic agent Drugs 0.000 description 5
- 238000009958 sewing Methods 0.000 description 5
- 230000003187 abdominal effect Effects 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 229920002994 synthetic fiber Polymers 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 239000013013 elastic material Substances 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229920000747 poly(lactic acid) Polymers 0.000 description 3
- 239000004626 polylactic acid Substances 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 210000005070 sphincter Anatomy 0.000 description 3
- 210000001215 vagina Anatomy 0.000 description 3
- 241000499489 Castor canadensis Species 0.000 description 2
- 241001269524 Dura Species 0.000 description 2
- 235000011779 Menyanthes trifoliata Nutrition 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229920000954 Polyglycolide Polymers 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 238000004026 adhesive bonding Methods 0.000 description 2
- 239000012984 antibiotic solution Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000002224 dissection Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 210000003041 ligament Anatomy 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 238000002559 palpation Methods 0.000 description 2
- 210000003516 pericardium Anatomy 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 239000004633 polyglycolic acid Substances 0.000 description 2
- -1 polytetrafluoroethylene Polymers 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 230000002787 reinforcement Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 210000003699 striated muscle Anatomy 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 238000012800 visualization Methods 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- LEBVLXFERQHONN-UHFFFAOYSA-N 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Chemical compound CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-UHFFFAOYSA-N 0.000 description 1
- GSDSWSVVBLHKDQ-UHFFFAOYSA-N 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Chemical compound FC1=CC(C(C(C(O)=O)=C2)=O)=C3N2C(C)COC3=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-UHFFFAOYSA-N 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 239000004812 Fluorinated ethylene propylene Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 208000006735 Periostitis Diseases 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000007698 birth defect Effects 0.000 description 1
- 229960003150 bupivacaine Drugs 0.000 description 1
- 229960003405 ciprofloxacin Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 238000005553 drilling Methods 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 238000002504 lithotomy Methods 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 229960001699 ofloxacin Drugs 0.000 description 1
- 210000004197 pelvis Anatomy 0.000 description 1
- 210000003460 periosteum Anatomy 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000002694 regional anesthesia Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0004—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse
- A61F2/0031—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra
- A61F2/0036—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra implantable
- A61F2/0045—Support slings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0063—Implantable repair or support meshes, e.g. hernia meshes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/005—Ingredients of undetermined constitution or reaction products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/043—Proteins; Polypeptides; Degradation products thereof
- A61L31/044—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00743—Type of operation; Specification of treatment sites
- A61B2017/00805—Treatment of female stress urinary incontinence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/02—Surgical instruments, devices or methods, e.g. tourniquets for holding wounds open; Tractors
- A61B17/0218—Surgical instruments, devices or methods, e.g. tourniquets for holding wounds open; Tractors for minimally invasive surgery
- A61B2017/0225—Surgical instruments, devices or methods, e.g. tourniquets for holding wounds open; Tractors for minimally invasive surgery flexible, e.g. fabrics, meshes, or membranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B2017/0496—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials for tensioning sutures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0096—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers
- A61F2250/0097—Visible markings, e.g. indicia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
- A61L2300/406—Antibiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
Abstract
The present invention relates to prefabricated urethral suspension slings (10), methods of making the slings, methods of attaching suture to the slings, kits comprising the slings, and methods of using the slings to treat urinary incontinence. The slings (10) comprise a biocompatible material having an elongate shape adapted for urethral suspension. The material has a central portion (12) extending longitudinally between a first end portion (14) and a second end portion (16). Each end portion (14, 16) of the sling (10) contains at least one suture receiving site (18). The suture receiving sites (18) are formed prior to surgery and may be reinforced through a variety of means. Sutures (36) may be attached to the suture receiving sites (18) during the manufacturing process or by the physician prior to or during surgery. Additionally, the end portions (14, 16) of the sling (10) containing the suture receiving sites (18) may be thicker than the central portion (12) of the sling.
Description
.1.
STABILIZATION SLING FOR USE IN
MINIMALLY INVASIVE PELVIC SURGERY
Field of the Invention The present invention relates to slings for use in improving urinary continence. More particularly, the present invention relates to prefabricated urethral stabilization or suspension slings, methods of making the slings and kits including the slings.
Background of the Invention Urinary incontinence is a widespread problem in the United States and throughout the world. Urinary incontinence affects people of all ages and can severely impact a patient both physiologically and psychologically.
In approximately 30% of the women suffering from urinary incontinence, incontinence is caused by intrinsic sphincter deficiency pSDI, a condition in which the valves of the urethral sphincter do not properly coapt. In approximately another 30% of incontinent women, incontinence is caused by hypermobility, a condition in which the muscles around the bladder relax, causing the bladder neck and proximal urethra to rotate and descend in response to increases in intraabdominal pressure. Hypermobility may be the result of pregnancy or other conditions which weaken the muscles. In an additional group of women with urinary incontinence, the condition is caused by a combination of ISD and hypermobility.
In addition to the conditions described above, urinary incontinence has a number of other causes, including birth defects, disease, injury, aging, and urinary tract infection.
Numerous approaches for treating urinary incontinence are available. One such approach involves the use of a sling. At the present time, however, surgeons using a sling based procedure must grow or harvest autologous tissue or purchase processed cadaveric tissue, animal tissue, or synthetic material from a supplier and fashion the sling during the surgical procedure. Thus, during surgery, the surgeon must cut the sling to the desired dimensions and shape, and attach sutures to the sling. in addition to increasing surgical expense, these steps increase the time required for and complexity of the procedure, thereby increasing surgical morbidity and mortality.
In addition, the slings currently in use are susceptible to tearing at the sites where the sutures are attached to the sling. If the suture attachment sites tear, the sling becomes dislodged and incontinence may result. Additional surgery is required to replace the dislodged sling and restore continence.
Thus, there remains a need for a prefabricated sling which overcomes the above deficiencies. U.S. Patent Na. 5,811,515, issued March 18, 1997 to Benderev et al., introduces pioneering minimally invasive percutaneous and transvaginal bladder neck stabilization approaches. The percutaneous approach of Benderev et al. involves stabilizing the bladder neck using a bone anchor which is percutaneously introduced from the abdominal side of the patient.
The transvaginal approach of Benderev et al. involves stabilizing the bladder neck using a staple or bone anchor which is transvaginally placed into the pubic bone. The slings of the present invention may be used in several urethral or bladder neck stabilization procedures, including the minimally invasive percutaneous and transvaginal procedures described below and those described in Benderev et al.
.2.
Summary of the Invention The present invention relates to prefabricated urethra) stabilization slings, methods of making the slings, methods of attaching sutures to the slings, kits comprising the slings, and methods of using the slings to treat urinary incontinence.
One aspect of the invention is a prefabricated sling for improving urinary continence which is made of a biocompatible material and has an elongate shape adapted for urethra) stabilization. The biocompatible material has a central portion extending longitudinally between a first end portion and a second end portion and at least a pair of suture receiving sites which comprise a first site located in the first end portion of the material and a second site located in the second end portion of the material. The first site is adapted for receiving at least a first suture and the second site is adapted for receiving at least a second suture. The first site and the second site are generally disposed along a line extending longitudinally relative to the sling.
In one embodiment of the sling, the biocompatible material is directionally oriented. For example, the biocompatible directionally oriented material may be longitudinally oriented.
In a further embodiment, the first and second end portions of the directionally oriented material have at Least one presewn edge and are generally at least twice as thick as the central portion. In yet another embodiment, the first and second suture receiving sites have an inner diameter at least equal to the diameter of the sutures.
In a further embodiment of the sling, the biocompatible material is absorbable. In some embodiments of the sling, the biocompatible material is woven.
In yet another embodiment of the sling, the biocompatible material is coated.
In some embodiments, the coating on the biocompatible material is absorbed after implantation to facilitate tissue ingrowth into the biocompatible material.
In another embodiment of the sling, the biocompatible material is impregnated with an antibiotic. In one embodiment, the sling is impregnated with bacitracin. In another embodiment, the sling is impregnated with polymixim. In another embodiment the sling is impregnated with neomycin.
in some embodiments, the sling is capable of releasing a drug. in further embodiments, the drug is released over time.
The sting may have a visual indicator for indicating the position of the sling relative to the urethra. The visual indicator may comprise at least one transversely extending line in the central portion of the material.
In some embodiments, the sling has a stabilizer for further strengthening and further reducing buckling of the sling, the stabilizer being located in the first and second end portions of the sling.
In some embodiments, the material around the periphery of the suture receiving sites is reinforced. In other embodiments, the suture receiving sites are strengthened with a reinforcing device.
Another aspect of the present invention is a prefabricated sling for improving urinary continence comprising a biocompatible material having an elongate shape adapted for urethra) stabilization. In this aspect of the invention, the biocompatible material has a central portion extending longitudinally between a first end portion and a second end portion. In this aspect of the invention, the sling also has integral attachment members for suspending the sling.
Yet another aspect of the present invention is a kit far performing a urethral stabilization. The kit comprises a sterile biocompatible material having an elongate shape adapted for urethral stabilization. The biocompatible material has a central portion extending longitudinally between a first end portion and a second end portion. The biocompatible material also has at least a pair of suture receiving sites. The pair of suture receiving sites comprises a first suture receiving site located in the first end portion of the biocompatible material and a second suture receiving site located in the second end portion of the biocompatible material. The first suture receiving site is adapted for receiving at least a first suture, and the second suture receiving site is adapted for receiving at least a second suture. The first suture receiving site and the second suture receiving site are generally disposed along a line extending longitudinally relative to the sling.
In one embodiment of the kit, the sling is packaged. In another embodiment of the kit, the first and second suture receiving sites are apertures. In still another embodiment of the kit, the biocompatible material has at least a first and a second suture secured thereto. In a further embodiment of the kit, the biocompatible material is filamentous.
In still another embodiment, the filamentous material is collagen coated. In some embodiments of the kit, the sutures are looped through the apertures.
Yet another aspect of the present invention is a method of making a sling for improving urinary continence.
A biocompatible material is cut into an elongate shape adapted for urethral stabilization such that the material has a central portion extending longitudinally between a first end portion and a second end portion. At least a pair of suture receiving sites is formed in the material prior to surgery. The pair of suture receiving sites comprises a first site located in the first end portion of the material and a second site located in the second end portion of the material. The first site is adapted for receiving at least a first suture and the second site is adapted for receiving at least a second suture. The first site and the second site are generally disposed along a line extending longitudinally relative to the sling. In one embodiment, the method further comprises the steps of securing at least a first suture to the first site and securing at least a second suture to the second site. In another embodiment, the method further comprises the step of sterilizing the sling. In yet another embodiment, the method further comprises the step of applying an antibiotic to the sling. In still another embodiment, the method further comprises the step of packaging the sting.
Yet another aspect of the present invention is a method of stabilizing a bladder neck to improve urinary incontinence. In one step of the method, a sling comprising a biocompatible material having an elongate shape adapted for urethral stabilization is provided. The material has a central portion extending longitudinally between a first end portion and a second end portion. The sling also comprises at least a pair of suture receiving sites. In another step of the method, a suture is secured to a bone anchor. In another step of the method, the anchor is positioned in a pubic bone. In yet another step of the method, the suture is secured to at least one of the suture receiving sites in the sling. The suture receiving sites are adapted for receiving at least one suture. The suture receiving sites comprise a first suture receiving site located in the first end portion of the material and a second suture receiving site located in the second end portion of the material. The first suture receiving site is adapted for receiving at least a first suture and the second suture receiving site is adapted for receiving at least a second suture.
The first suture receiving site and the second suture receiving site are generally disposed along a line extending longitudinally relative to the sting. In another step of the method, the bladder neck is stabilized with the sling. In one embodiment, the method further comprises introducing the sling percutaneously. In another embodiment of the method, the sling is introduced without invasive surgery.
Brief Description of the Drawines Figure 1 is a plan view of a preferred embodiment of the sling of the present invention.
Figure 2A is a plan view of a parallelogram shaped embodiment of the sling of the present invention.
Figure 2B is a plan view of a hexagonal shaped embodiment of the sling of the present invention.
Figure 2C is a plan view of a rectangular shaped embodiment of the sling of the present invention.
Figure 3A is a plan view of a preferred embodiment of the sling of the present invention showing preferred dimensions.
Figure 38 is a cross-sectional view of the sling taken along line 3B-3B of Figure 3A.
Figure 4A is a partial top view of an end portion of a sling having a single suture receiving site.
Figure 4B is a partial top view of a rounded end portion of a sling having two suture receiving sites.
Figure 4C is a partial top view of an end portion of a sling having three suture receiving sites.
Figure 5A is an enlarged top view of an end portion of a sling in which the suture receiving site is an aperture.
Figure 5B is a cross-sectional view of the end portion taken along line 5B-5B
of Figure 5A.
Figure 5C is an enlarged top view of an end portion of a sling having a reinforcing device in the suture receiving site.
Figure 5D is a cross-sectional view of the end portion taken along line 5D-5D
of Figure 5C.
Figure 5E is an enlarged top view of an end portion of a sling having an alternative reinforcing device in the suture receiving site.
Figure 5F is a cross-sectional view of the end portion taken along line 5F-5F
of Figure 5E.
Figure 5G is an enlarged top view of an end portion of a sling having reinforced material around the periphery of the suture receiving site.
Figure 5H is a cross-sectional view of the end portion taken along line 5H-5H
of Figure 5G.
Figure 51 is an enlarged top view of an end portion of a sling having reinforced material around an alternative suture receiving site.
Figure 5J is a cross-sectional view of the end portion taken along line 5J-5J
of Figure 51.
Figure 5K is an enlarged top view of an end portion of a sling in which the suture receiving site is an aperture and the material around the periphery of the suture receiving site has been reinforced by heat seating or ultrasonically sealing.
Figure 5L is a cross-sectional view of the end portion taken along line 5L-5L
of Figure 5K.
Figure 6A is a plan view of an unfolded parallelogram shaped piece of biocompatible material.
.5. _ Figure 6B is a plan view of a hexagonal shaped piece of material obtained by folding the material of Figure 6A as indicated by the arrows in Figure 6A.
Figure 6C is a plan view of a hexagonal shaped sling in which apertures have been formed as suture receiving sites in the end portions of the sling.
Figure 6D is a cross-sectional view of the hexagonal shaped sling taken along line 6D-6D of Figure 6C.
Figure 6E is the cross-sectional view of Figure 6D showing sutures secured to the apertures of the sling.
Figure 6F is a plan view of an unfolded rectangular shaped piece of biocompatible material.
Figure 6G is a plan view of a rectangular shaped piece of material obtained by folding the material of Figure 6F as indicated by the arrows in Figure 6F.
Figure 6H is a plan view of a rectangular sling in which apertures have been formed as suture receiving sites in the end portions of the sling.
Figure 61 is a crass-sectional view of the rectangular shaped sling taken along line 61-61 of Figure 6H.
Figure 6J is the cross-sectional view of Figure 61 showing sutures secured to the apertures of the sling.
Figure 6K is a plan view of an unfolded rectangular piece of biocompatible material.
Figure 6L is a plan view of a parallelogram shaped piece of material obtained by folding the material of Figure 6K as indicated by the arrows in Figure 6K.
Figure 6M is a plan view of a parallelogram shaped sling in which apertures have been formed as suture receiving sites in the end portions of the sling.
Figure 6N is a cross-sectional view of the parallelogram shaped sling taken along fine 6N-6N of Figure 6M.
Figure 60 is the cross-sectional view of Figure 6N showing sutures secured to the apertures of the sling.
Figure 7A is a schematic plan view of a paralletogram shaped piece of biocompatible material having longitudinally oriented filaments, grains, striations, or polymeric chains.
Figure 7B is a cross-sectional view of the material taken along line 7B-7B of Figure 7A.
Figure 7C is an enlarged view of the material taken along line 7C-7C of Figure 7A.
Figure 7D is an enlarged schematic view of biocompatible material having transversely oriented filaments, grains, striations, or polymeric chains. .
Figure 7E is an enlarged schematic view of biocompatible material having diagonally oriented filaments, grains, striations, or polymeric chains.
Figure 7F is a schematic plan view of a hexagonal shaped sling obtained by folding the material of Figure 7A as indicted by the arrows in Figure 7A and forming apertures as suture receiving sites in the end portions of the sling.
Figure 7G is an enlarged top view of the sling taken along line 7G-7G of Figure 7F showing the filaments, grains, striations, or polymeric chains in an upper layer of an end portion of the sling crossing the filaments, grains, striations, or polymeric chains in the underlying layer.
Figure 8A is an enlarged top view of an end portion of a sling having a suture tooped through a plurality of suture receiving sites.
Figure 8B is a cross-sectional view of the sling taken along line 8B-8B of Figure 8A.
Figure 8C is an enlarged top view of an end portion of a sling having a suture threaded through a suture .
receiving site.
Figure 8D is a cross-sectional view of the sling taken along line 8D-8D of Figure 8C.
Figure 8E is an enlarged top view of an end portion of a sling showing a suture looped around the suture receiving site and an edge of the sling.
Figure 8F is a cross-sectional view of the sling taken along line 8F-8F of Figure 8E.
Figure 9A is a plan view of an end portion of a sling having a stabilizer attached thereto.
Figure 9B is a cross-sectional view of the sting taken along line 9B-9B of Figure 9A.
Figure 9C is a plan view of an end portion of a sling having a stabilizer between the suture receiving sites.
Figure 9D is a cross-sectional view of the sling taken along line 9D-9D of Figure 9C.
Figure 10A is a plan view of a generally rectangular shaped sling with bilaterally extending integral attachment members.
Figure 10B is a plan view of a generally hexagonal shaped sling with bilaterally extending integral attachment members.
Figure 11 is a sagittal section of a female pelvis illustrating the location of the sling of the present invention relative to the bladder neck and the pubic bone.
Figure 12 is a schematic cross-sectional view taken through the urethra and upper vaginal wall illustrating an incision in the upper vaginal wall.
Figure 13 is a schematic cross-sectional view taken through the urethra and upper vaginal wall illustrating a bilaterally extending pocket created by blunt dissection.
Figure 14 is a schematic view of a sling of the present invention positioned in the pocket of Figure 13, the sling being suspended from sutures secured to a bone anchor implanted in the pubic bone.
Detailed Description of the Preferred Embodiments The present invention relates to prefabricated slings for use in urethral floor reconstruction. More particularly, the slings are useful for improving or maintaining urinary continence such as by suspending, stabilizing andlor slightly compressing the urethra of an incontinent patient. The slings are particularly useful for treating patients suffering from incontinence caused by Intrinsic Sphincter Deficiency (ISD) andlor hypermobility. The slings may also be used to treat other disorders in which stabilization andlor compression of the urethra would be beneficial.
The present slings are designed to be implanted in a patient suffering from incontinence using the medical procedure described in more detail below. During implantation, the sling is preferably positioned beneath the bladder neck so that the urethra extends across the center of the sling. The sting is biased towards the urethra through tension applied to the sling by sutures or other attachment means, which are preferably anchored to the pubic bone.
The resulting bias stabilizes andlor slightly compresses the urethra so that continence is maintained.
.7.
Although urethral slings have previously been used to treat incontinence, the present slings are prefabricated, eliminating the need for the surgeon to prepare them for use during the surgical procedure. The present slings are _ supplied to the physician in shapes and dimensions adapted for urethral stabilization or suspension, eliminating the need for the surgeon to cut the sling material during surgery. In addition, the present slings are provided with suture receiving sites already prepared so that the surgeon need not manufacture them during surgery. The slings may also be provided with reinforced suture receiving sites to reduce the incidence of tearing about the point of suture attachment. Because the surgeon need not fabricate the sling during surgery, the time required for the surgical procedure is reduced.
In some embodiments, the slings are provided with the sutures preattached.
Alternatively, the slings may have preformed integral attachment members which, like the sutures, allow the sling to be suspended from structures such as the pubic bone. In either case, the need for the surgeon to attach sutures to the sling during surgery is eliminated, thereby simplifying the implantation procedure.
The foregoing features of the present invention overcome the above-discussed deficiencies of slings currently in use. By simplifying and shortening the surgical procedure, use of the slings of the present invention results in decreased surgical morbidity and mortality.
Referring to Figure 1, there is disclosed a plan view of a preferred embodiment of the sling 10 of the present invention. The sling of Figure 1 has been cut into a generally elongate shape adapted for urethral stabilization, with a central portion 12 extending between a first end portion 14 and a second end portion 16.
Suture receiving sites 18 are prefabricated in the first and second end portions 14, 16 of the sling 10. The sling preferably also has a visual indicator 20. These and other features of the present invention will be described in more detail below after discussing the materials from which the sling can be constructed.
The sling may be fabricated from any of a variety of synthetic or naturally occurring biocompatible materials. Such materials may be filamentous or non-filamentous, elastic or inelastic, and may be porous, microporous, perforated, or impermeable. The properties of the sling may be selected as appropriate based on the surgical procedure used to implant the sling and the application for which the sling is used.
Filamentous materials suitable for use in the slings of the present invention include cadaveric or animal tissue such as fascia Iota, rectus fascia or processed coNagen. Synthetic materials such as polyester, polyurethane, or nylon can also be used. The synthetic filamentous material can be woven or non-woven. Filaments made from synthetic materials may be braided together to form strands or threads which can be braided or woven together to form strips of fabric. Preferably, the synthetic filamentous material is polyester.
Non-filamentous materials suitable for use in the slings of the present invention include silicone, polytetrafluoroethylene (PTFEI, polyethylene terephthalate (PET), PTFE, FEP, or thin films such as latex.
As will be apparent to one skilled in the art, the elasticity of the sling material may also be selected based on the type of surgical procedure for which the sling is being used. A
suitable elastic material is knitted polyester.
.8.
As will be apparent to one skilled in the art, inelastic or minimally elastic materials may be preferred for certain procedures such as those in which the sting is used to create an immobile floor. A preferred minimally elastic material is woven polyester.
The porosity of the material may also be selected based on the type of surgical procedure for which the sling is being used. For example, pores, micropores, or perforations permit tissue ingrowth, which is advantageous to stabilize the sling and reduce erosion from constant motion.
Additionally, the sling material may be impregnated with antibiotics or other agents which can be delivered from the surface of the sling as well as through the pores, micropores or perforations. Impregnation with antibiotics or other agents may be facilitated by coating the sling with collagen.
Impermeable materials may also be useful in certain applications of the sling.
Representative impermeable materials include nylons and polyester. A preferred impermeable material is polyester.
A coating may also be applied to the sling. The coating may be used to deliver a number of compounds, such as antibiotics, heparin, immunosuppressant agents or other drugs. In some embodiments, the drug may be released over time. The coating also blocks the interstices of the underlying sling material, thereby decreasing the risk of infection by sequestering the interstices of the sling from contact with microorganisms encountered during implantation of the sling. Preferably, the coating is absorbed after implantation to facilitate tissue ingrowth into the interstices, pores, micropores andlor perforations of the sling material.
Suitable coatings include polyglycolic acid, polylactic acid, blends of polyglycolic acid and polylactic acid, gelatin, polyvinyl alcohol, and polyvinyl pyrrolidone. A preferred coating is a smooth layer of collagen, such as that provided on the Hemashield° woven double velour available from Meadox.
(Meadox Medical, 112 Beaver Drive, Oakland, NJ 07436 or Boston Scientific Corporation, One Boston Scientific Place, Natick, MA 01760.) The smooth collagen coating protects the interstices of the underlying sling material from bacterial contact during implantation, thereby decreasing the risk of infection as previously discussed.
Additionally, the collagen coating facilitates the uptake of antibiotics to reduce the risk of infection as discussed below.
After placement in the body, the collagen is gradually absorbed, facilitating tissue ingrowth into the underlying filamentous mesh. The collagen coating may also enhance tissue compatibility.
The slings of the present invention may also be made of absorbable materials.
Such absorbable slings preferably remain structurally intact for at least three months while supporting tissue ingrowth. Thereafter, the slings may be fully absorbed. Preferably, the stings are fully absorbed over a period of 3-6 months following the three month period in which the sling is intact. Preferably, the absorbable sling is made of polylactic acid or polylactic acidlpolyglycolic acid copolymers.
The slings of the present invention may be fabricated from directionally oriented biocompatible materials.
Such materials include filamentous materials in which the orientation of the filaments is directionally ordered, as well as grained or striated materials in which the grains or striations are directionally ordered. Alternatively, the material may be a polymeric material in which the orientation of the polymeric chains comprising the material is directionally ordered. The polymeric material may or may not be cross-linked.
.g.
The filaments, grains, striations, or polymeric chains in such materials may be oriented in a single direction or may be multidirectional. Suitable directionally oriented materials include synthetic materials such as Trelex° _ Natural Mesh (Meadox Medical, 112 Beaver Drive, Oakland, NJ 07436 or Boston Scientific Corporation, One Boston Scientific Place, Natick, MA 01760.), Hemashield°, and woven and knitted polyester.
Alternatively, the directionally oriented material may be natural material such as grained or striated tissue.
The tissue may be an allograft, xenograft, or autologous tissue. One advantage of autologous tissue is its ability to revascularize and regrow after implantation.
Tissue for use in allografts can be obtained from cadavers. Cadaveric tissue can be harvested according to techniques well known to those skilled in the art and may be selected to minimize the risk of rejection. However, non-cadaveric tissue is generally preferred because of patient preference and the perceived risk of cross-contamination. Although the cadaveric tissue may be absorbed after implantation, the scar tissue which replaces the cadaveric tissue provides support for the bladder neck.
Representative sources of autologous tissue for use in the present slings include striated muscle, fascia Iota, rectus fascia, dura, pericardium and the vaginal wall. The same tissue sources may also be used for allografts.
Typical sources of xenograft tissue include striated muscle, bovine fascia, dura, pericardium and collagen.
In addition to the synthetic and naturally occurring biocompatible materials enumerated above, those ski8ed in the art will appreciate that a variety of other materials may be readily employed in the slings of the present invention.
In addition to the elongate octagonal sling illustrated in Figure 1, the slings of the present invention may be cut into a number of other shapes. For example, several alternative elongate shapes suitable for use in the present invention are shown in Figures 2A-2C. These include parallelograms such as rhomboids (Figure 2AE, hexagons (Figure 2B~, and rectangles (Figure 2C). In addition, the end portion of the sling may be cut into a rounded shape, such as that illustrated in Figure 4B. The optimal shape of the sling is related to anatomical considerations as well as the surgical procedure used to introduce the sling. For instance, slings having rounded ends (Figure 4B) or tapered ends, such as the hexagon (Figure 2B), parallelogram (Figure 2Ah and octagon (Figure 1~, may facilitate insertion into the pocket formed during the surgical procedure discussed in more detail below, since the pocket may not be precisely rectangular.
The optimal dimensions of the sling can be varied considerably to suit particular design criteria desired for a particular application and still embody the present invention. For example, optimal sling dimensions are dependent upon anatomical considerations and the surgical procedure used to introduce and attach the sling. For instance, the optimal length of the sling may be influenced by whether the surgeon prefers to attach a long strip of material to the pubic bone or abdominal musculature with a bone anchor or other securing device. In such procedures, the sting may be up to 30 cm in length and may be 1-5 cm in width. Preferably, the long stings used in such procedures are 15-30 cm in length and 3-5 cm in width. Shorter slings may be preferred for procedures in which the sling is suspended by a suture bridge. Such slings may be 2.5-7cm in length and 1-5cm in width.
The optimal dimensions of the sling may also be influenced by the sling material selected. For instance, the thickness of the sling material may be dependent on the material selected and the strength and tear resistance required for a particular application of the sling.
The dimensions of the preferred embodiment of Figure 1 are shown in Figures 3A
and 3B. The approximate dimensions, in inches, are as follows: A=0.30; B-0.79; C=0.12; D=0.43; F=0.20;
G=0.24; H=0.015; I-0.030;
and J=0.98. Angle E-22~.
As indicated above, the sling 10 is preferably provided with a visual indicator 20. The visual indicator enables the surgeon to position the sling relative to the urethra so that the urethra generally extends across the center of the sling. In one embodiment, the visual indicator 20 comprises two transversely extending dashed lines in the central portion 12 of the sling 10 as illustrated in Figure 1. However, those skilled in the art will recognize that a variety of other types of visual indicators, including radiopaque indicators, could be used in accordance with the present invention.
The sling of the present invention preferably also has at least one suture receiving site formed in both the first and second end portions of the sling. Preferably, the suture receiving site is an aperture. The aperture may be formed by die stamping the sling material ultrasonic cutting, heat cauterizing, or piercing with a hot poker.
Alternatively, the suture receiving site may be sling material as discussed below in regard to Figures 51 and 5J.
The suture receiving site is adapted for receiving at least one suture.
Preferably, the suture receiving site has an inner diameter at least equal to the diameter of the suture to be received therein. In the preferred embodiment depicted in Figure 1, both the first and second end portions of the sling have two apertures which are equally displaced from the central longitudinal axis of the sling. However, numerous alternative embodiments are also contemplated by the present invention.
For example, some embodiments of the sling, such as that depicted in Figure 4A, have only one suture receiving site formed per end portion. In such embodiments, the suture receiving site 18 is preferably located along the central longitudinal axis 19 of the sling.
Other embodiments of the sling have 3 or more suture receiving sites formed per end portion. In such embodiments, preferably at least one suture receiving site 18 is located along the central longitudinal axis 19 of the sling with the other suture receiving sites 18 being located symmetrically about the central longitudinal axis 19 as illustrated in Figure 4C.
Preferably, in embodiments in which the number of suture receiving sites in each end portion of the sling is odd, at least one suture receiving site in each end portion of the sling is located along the central longitudinal axis of the sling as shown in Figures 4A and 4C. In those embodiments in which the number of suture receiving sites in each end portion of the sling is even, the suture receiving sites are preferably disposed symmetrically about the central longitudinal axis of the sling as depicted in Figures 1 and 4B.
The use of a plurality of suture receiving sites in each end portion of the sting results in reduced buckling of the sling after implantation compared to embodiments having a single suture receiving site at each end of the sling. Thus, embodiments having a plurality of suture receiving sites in each end portion are preferred.
Although several examples of the locations and number of he suture receiving sites in the end portions of the present slings have been provided above, those skilled in the art will appreciate that additional configurations fall within the scope of the present invention. It will also be appreciated by those skilled in the art that the various configurations and numbers of suture receiving sites described above may be utilized with any of the sling shapes or biocompatible materials described above.
Figure 5 shows various types of suture receiving sites which may be used in the slings of the present invention. In Figures 5A and 5B, the suture receiving site is an aperture formed in the sling material. This type of suture receiving site is employed in the embodiment shown in Figure 1.
Preferably, the material around the periphery of the suture receiving sites is reinforced by heat sealing or ultrasonic sealing.
In addition, the suture receiving sites can be strengthened in order to minimize the possibility of tearing.
For instance, one piece reinforcing devices may be inserted in the apertures in the sling material. As shown in Figures 5C and 5D, the one piece reinforcing device 22 has an upper rim 24 and a lower rim 26 between which the sling material bordering the suture receiving site is enclosed. Although the upper rim and the lower rim are shown parallel to one another in Figure 5D, alternative embodiments are contemplated in which the upper and lower rims converge towards each other with the sling material therebetween. The upper rim and the lower rim may also be provided with friction enhancing retention structures to minimize the risk of dislodgement of the one piece reinforcing device. Preferably, the one piece reinforcing device 22 is fabricated from biocompatible plastics or metals, such as stainless steel or titanium.
Alternatively, the area around an aperture 18 in the sling material may be strengthened by inserting a multiple piece reinforcing device 28 therein. As illustrated in Figures 5E and 5F, the multiple piece reinforcing device 28 has a first piece 30 and a second piece 32, which interlock and enclose the sling material bordering the suture receiving site. Although the first piece and the second piece are shown parallel to one another in Figure 5F, alternative embodiments are contemplated in which they converge towards each other as discussed above with respect to the one piece reinforcing device. The first piece and the second piece may also be provided with friction enhancing retention structures to minimize the risk of dislodgement of the multiple piece reinforcing device.
Preferably, the multiple piece reinforcing device 28 is fabricated from biocompatible plastics or metals, such as stainless steel or titanium.
Yet another way of reducing the risk of tearing comprises reinforcing the sling material around the periphery of the suture receiving sites. Slings having such reinforced material around the periphery of the suture receiving site are depicted schematically in Figures 5G through 5J. In Figures 5G and 5H, the suture receiving site is an aperture.
In Figures 51 and 5J, the suture receiving site comprises sling material. In the embodiment of Figures 51 and 5J, the sling material at the suture receiving site provides a puncture target into which the surgeon can insert the suspending suture. In Figures 5K and 5L the suture receiving site is an aperture and the periphery of the suture receiving site is reinforced by heat sealing or ultrasonically sealing.
Preferably, the material around the periphery of the suture receiving sites is reinforced by heat sealing or ultrasonic sealing. The reinforced material 34 around the periphery of the suture receiving site shown in Figures 5G through 5L may be formed in a variety of ways, such .12.
as by heat sealing, ultrasonically sealing, or sewing the area of the sling material along the periphery of the suture receiving site.
In further embodiments of the present invention, the periphery of the suture receiving sites is strengthened by making the end portions of the sling thicker than the central portion as shown in Figures 6A-60. One way to fabricate slings in which the end portions are thicker than the central portion is to fold the end portions of the sling.
For example, a hexagonal shaped piece of material, shown in Figure 6B, may be formed by folding the parallelogram shaped piece of biocompatible material shown in Figure 6A along the lines indicated in Figure 6A. Alternatively, the hexagonal material of Figure 6B may be formed by folding a trapezoidal piece of material, as will be apparent to one skilled in the art. Suture receiving sites may be formed in the hexagonal shaped intermediate of Figure 6B to form the hexagonal shaped sling of Figure 6C, in which the end portions 14, 16 are generally twice the thickness of the central portion 12 of the sling. A cross-sectional view of the hexagonal shaped sling depicting the double thickness end portions is shown in Figure 6D. Figure 6E illustrates a suture 36 secured in the suture receiving site 18. The suture can be secured to the suture receiving site during the manufacturing process of the sling or by the physician prior to or during surgery.
In another embodiment, a rectangular piece of material, shown in Figure 6G, may be formed by folding the rectangular piece of biocompatible material shown in Figure 6F along the lines indicated in Figure 6F. Suture receiving sites may be formed in the rectangular shaped intermediate of Figure 6G to form the rectangular sling of Figure 6H, in which the end portions 14, 16 are generally twice the thickness of the central portion 12 of the sling.
A cross-sectional view of the rectangular shaped sling depicting the double thickness end portions is shown in Figure 61. Figure 6J illustrates a suture 36 secured in the suture receiving site 18 as discussed above with regard to Figure 6E.
In a further embodiment, a rhomboid shaped piece of material, shown in Figure 6L, may be formed by folding the rectangular piece of biocompatible material shown in Figure 6K
along the lines indicated in Figure 6K.
Suture receiving sites may be formed in the rhomboid shaped intermediate of Figure 6L to form the rhomboid shaped sling of Figure 6M, in which the end portions 14, 16 are generally twice the thickness of the central portion 12 of the sling. A cross-sectional view of the rhomboid shaped sling depicting the double thickness end portions is shown in Figure 6N. Figure 60 illustrates a suture 36 secured in the suture receiving site 18 as discussed above with regard to Figures 6E and 6J.
Those skilled in the art will appreciate that slings in which the end portions are thicker than the central portion may be made in any of the shapes and configurations disclosed herein and are not limited to the shapes illustrated in Figures 6A-60.
In some embodiments of the present invention, at least one edge 38, 40, 42 or 44 of each double thickness end portion 14, 16 is secured to an adjacent layer of the sling either during manufacturing of the sling or by the physician prior to or during the surgical procedure. Alternatively, the sling may be supplied to the surgeon with at least one edge 38, 40, 42 or 44 of each double thickness end portion 14, 16 already secured. Preferably, the edge 38 closest to the central portion 12 is sewn. More preferably, all edges 38, 40, 42 and 44 are secured. In those embodiments in which the sting is made from natural tissue, the edge 42 where the fold was made is preferably not secured, although the other edges 38, 40 andlor 44 of the double thickness end portions may be secured. Numerous methods familiar to those skilled in the art may be used to secure the edges, such as sewing, heat sealing, ultrasonic sealing, stapling or gluing. Preferably, the edges are secured by sewing during the manufacturing process or prior to surgery, and by sewing, stapling or gluing during the surgical procedure.
As will be apparent to one of skill in the art, slings having end portions that are thicker than the central portion can be made in a variety of ways other than those described above. For example, the sling material may be folded over on itself more than once to produce slings with end portions more than twice as thick as the central portion. Alternatively, an additional layer or layers of separately cut material could be secured to the end portions of the sling, thereby producing a sting having end portions of varying thickness. Slings having two or more layers of material in both the end portions and the central portion are also contemplated. Such slings can be formed by securing the upper layer or layers of sling material to the lower layer or layers using the methods discussed above.
In addition to the resistance to tearing provided by slings in which the suture receiving sites are located in end portions that are thicker than the central portion, a further benefit is provided by securing the upper layer of the vertical edge 38 to the lower layer of the sling. In particular, the secured vertical edge 38 acts as a reinforcing rib which reduces buckling of the sling when the sling is placed under tension after implantation in the patient.
If the suture receiving sites are strengthened using the one piece reinforcement devices, two piece reinforcement devices, or reinforced material around their periphery as described above, the edges 40, 42, 44 of the double thickness end portions of the sling may be secured. The vertical edge 38, however, may be secured to reduce buckling as described above.
Yet a further advantage is provided by forming end portions having double thickness in slings made of directionally oriented materials such as the materials shown in Figures 7A-7G
. The directionally ordered filaments, grains, striations or polymeric chains may be oriented in a variety of directions. For example, Figures 7C-7E illustrate enlarged views of sling materials having longitudinally (Fig. 7C1, transversely (Fig. 7D1, and diagonally (Fig. 7E) oriented filaments, grains, striations or polymeric chains 46, all of.which are suitable for use in the present invention.
Figure 7B is a schematic view of grained materials suitable for use with the present invention. Those skilled in the art will appreciate that the grained materials may have ridges or grooves therein, or may have a smooth surface.
Materials having multidirectional filaments, grains, striations or polymeric chains are also suitable for use in the present invention.
The parallelogram or rhomboid shaped material of Figure 7A can be folded along the indicated lines to form the hexagonal shaped sling having double thickness end portions shown in Figure 7F as described above with regard to Figures 6A-6E. As can be seen in Figures 7F and 7G, when the directionally oriented material is folded over on itself, the filaments, grains, striations or polymeric chains in the upper layer of the double thickness end portion cross the filaments, grains, striations or polymeric chains in the lower layer of the end portion. This nonparallel orientation of the layers of the material relative to each other provides additional protection against tearing in the regions of the sling surrounding the suture receiving sites by having the strength of the grain perpendicular to the suture pull direction.
Slings having two or more layers of directionally oriented material in both the end portions and the central portion, wherein the filaments, grains, striations or polymeric chains in the different layers cross are also contemplated.
In another embodiment, the slings may have a stabilizer attached to the end portions 14, 16 to reduce buckling of the sling 10 and to provide additional strength to the sling 10, as depicted in Figures 9A-9D. Preferably, the stabilizer is made of metal or plastic. The stabilizer may be attached to the sling in a variety of manners such as sewing, heat sealing, mechanical securement, or capturing the stabilizer between a fold in the sling material. In some embodiments, the stabilizer may also be provided with friction enhancing retention structures to minimize the risk of dislodgement of the stabilizer.
In one embodiment, the stabilizer may be attached to an edge at each end of the sling as illustrated in Figures 9A and 9B. The stabilizer may comprise a first side 68, a second side 70, and an intermediate section 72 disposed between the first side 68 and the second side 70. In this embodiment, the stabilizer preferably contacts both sides of the sling 10.
In an alternate embodiment, the stabilizer may comprise a single section 73 which is disposed between the suture receiving sites 18 and is attached to one side of the sling as illustrated in Figures 9C and 9D.
Those skilled in the art will appreciate that additional stabilizer designs and locations are possible. For example, a stabilizer which is located at each end of the sling may contact a single side of the sling 10. In other embodiments, the sling may have one or more stabilizers in the central portion 12 in addition to the stabilizers in the end portions 14, 16. In addition, those skilled in the art will appreciate that the stabilizers may be used in conjunction with any of the sling embodiments described herein.
As previously discussed, the slings can be supplied to the surgeon with the sutures preattached or the sutures can be attached to the suture receiving sites by the surgeon. In either case, a variety of suture attachment methods are contemplated by the present invention.
For example, Figure 8A shows an enlarged top view of an end portion of a sling having two suture receiving sites 18 with a suture 36 secured thereto. In this embodiment, the suture 36 is looped through the suture receiving sites 18, as illustrated in the cross-sectional view of Figure 8B.
Alternatively, the suture can be threaded through one suture receiving site and out the other suture receiving site without looping through the sling material therebetween.
Alternatively, the suture 36 can be threaded through a single suture receiving site 18 as illustrated in Figures 8C and 8D.
Another method of attaching the suture to the sling is illustrated in Figures 8E and BF. In accordance with this method, the suture 36 is looped around the suture receiving site 18 and the edge of the sling.
While Figures SA-8E show a variety of methods for attaching the suture to the sling, those skilled in the art will appreciate that other methods may also be used.
- WO 98/35b32 PCT/US98/030bb .15.
Yet another method of attaching the suture 36 utilizes a connector to link the suture to the sling. Suitable connectors for linking the suture to the sling are disclosed in the copending U.S. Patent Application entitled "Method and Apparatus for Minimally Invasive Pelvic Surgery," (11ESITEC.028A), filed February 13, 1998 and the identically titled U.S. Provisional Patent Application Serial Ne. 60)038,380 filed February 13, 1997. In such embodiments, the sling has a ring member therein to permit the connector to be attached to the sling. Ring members suitable for attaching the connector are also disclosed in the copending U.S. Patent Application entitled "Method and Apparatus for Minimally Invasive Pelvic Surgery," filed simultaneously herewith and the identically titled U.S. Provisional Patent Application Serial No. 601038,380 filed February 13, 1997.
Those skilled in the art will appreciate that a variety of other suture attachment methods can be used in accordance with the present invention.
The present invention also includes prefabricated slings having integral attachment members 148. Such slings can be die cut or ultrasonically cut out of a solid sheet of biocompatible material. Preferably, the slings having integral attachment members are cut from one length of material and the edges are heat sealed. Alternatively, the integral attachment members may comprise trailing filaments such as longer strands in a woven sling. In a further embodiment, the integral attachment members comprise filaments interwoven through the sling material. The function of the integral attachment members 148 is similar to that of the sutures 36, which allow the surgeon to suspend the sling from a structure, such as the pubic bone as described in more detail below.
Representative examples of slings having integral attachment members are depicted in Figures 10A and 108.
Figure 10A shows a generally rectangular shaped sling 110 in which bilaterally extending integral attachment members 148 are formed from the same piece of material as the sling. Figure 108 shows a generally hexagonal shaped sling 110 in which bilaterally extending integral attachment members 148 are formed from the same piece of material as the sling. Those skilled in the art will appreciate that slings with integral attachment members having configurations other than those shown in Figures i0A and tOB are also contemplated by the present invention.
The slings of the present invention may be individually packaged andlor sterilized prior to purchase. The packaging may protect the sling during storage. For example, in embodiments in which the sling material comprises a collagen coated filamentous material, the packaging may protect the sling from damage by ultraviolet light. The sling may be soaked in an antibiotic solution, such as a solution of neomycin, bacitracin, or polymixim, to prevent microorganisms from collecting on and colonizing the surface of the sling during manipulation, thereby reducing the risk of infection following implantation of the sling. The sting may also be sterilized by ethylene oxide or irradiation.
Uptake and delivery of the antibiotic may be enhanced by using a coated sting as described above.
In embodiments in which the sling is made of natural tissue, the sling may be stored in glutaraldehyde or freeze dried. Prior to use in the surgical procedure, the natural tissue may be preconditioned by soaking the sling in a saline solution, such as any standard commercially available saline solution.
The present invention also includes a stabilization sting kit for maintaining urinary continence. Preferably, the kit comprises a prepackaged sling. More preferably, the kit comprises a sterilized sling. In one embodiment, the kit includes a sling having sutures secured thereto. Alternatively, the sling included in the kit may have integral attachment members as described above.
A minimally invasive percutaneous method of sling delivery and stabilization to treat an incontinent patient will now be described with reference to Figures 11 - 14. Preoperatively, the patient receives broad spectrum antibiotics, such as gentamicin and ampicillin. The patient is placed in the dorsal lithotomy position and regional or general anesthesia is administered. Preparation of the patient emphasizes isolation of the anus with a stapled towel or plastic drape. A Foley catheter is placed.
An approximately 1-2 centimeter midline incision 52 is made in the upper vaginal wall 54 beneath the bladderneck, such as at the urethro-vesical junction, as illustrated in Figure 12. The surgeon then inserts an instrument such as surgical scissors through the incision in the upper vaginal wall and bluntly dissects the tissue 58 on both sides of the urethra 56 to create a bilaterally extending pocket 60, which is illustrated in Figure 13.
The bilaterally extending pocket can also be created and the sling can be inserted using a variety of other minimally invasive instrumentslmethods including the transvaginal, hiatal and percutaneous approaches disclosed in the copending U.S. Patent Application entitled "Transvaginal Anchor Implantation Device," Serial No. 081744439 filed November 8, 1996, the copending U.S. Patent Application entitled "Percutaneous and Hiatal Devices and Methods for Use in Minimally Invasive Pelvic Surgery" (VESITEC.029A1. filed February 13, 1998, the identically titled U.S. Provisional Patent Application Serial No. 601038,171, filed February 13, 1997, the copending U.S. Patent Application entitled "Method and Apparatus for Minimally Invasive Pelvic Surgery" (VESITEC.028A), filed February 13, 1998, and the identically titled U.S. Provisional Patent Application Serial No. 601038,380, filed February 13, 1997.
For example, these other approaches may be employed when the physician desires to attach a long strip of material to the pubic bone or other structures such as the abdominal musculature with a bone anchor or other securing device. In such approaches, an opening capable of accommodating the long strip of material is created in the body tissue, the sling is introduced into the opening in the body tissue, and the sling is attached directly or indirectly to the pubic bone or other structures such as the abdominal musculature.
Either before or after creating the pocket 60, a bone~anchor 62, such as a screw in anchor, a push in anchor, or a punch in anchor, is introduced into the pubic bone 64 for fixation of suspensory sutures, with or without pre-drilling a hole in the pubic bone. For instance, the bone anchor is introduced using a bone anchor implantation device of a type such as that illustrated in Figures 15-19 of copending U.S.
Application Serial No. 081385,897, filed February 9, 1995. Bone anchor sites are located by placing the bone anchor implantation device on the body over the area of the pubic bone after visualization or digital palpation over the bone. The surgeon then extends the bone probes distally until both probes have made contact with the pubic bone.
Preferably, one anchor 62 for each side (two per patient) is implanted into the tubercle portions of the pubic bone 64 (approximately two centimeters lateral to the symphysis pubisl. Preferably, the eyelet of the anchor is recessed below the surface of the bone or flush with the surface of the bone. The anchor 62 preferably has a suture 36 slidably secured thereto prior to - WO 98/35632 PCT/~JS98/03066 .17.
implantation of the anchor into the pubic bone so that a first suture end and a second suture end extend from the implanted anchor after removal of the anchor driver.
Two separated approximately one inch transverse incisions are made over the pubic bone as illustrated in the U.S. Patent No. 5,611,515, issued March 18, 1997 to Benderev et al., and dissection is carried down to the area of the rectus fascia. The first end of the anchored suture is manually placed into a suture channel of a suture passer of a type such as that illustrated in Figures 45 and 45a of the above incorporated U.S. Patent No.
5,611,515, issued March 18, 1997 to Benderev et al. The probe is moved distally to lock the suture therein.
Beginning on the right side, the suprapubic wound is stretched cephalad to allow the vertical passage of the suture passer through the rectus fascia with the probe tip fully exposed.
Distal advancement of the suture passer is accomplished with the tip proximally retracted within the probe guide. The suture passer is acutely angled into the abdomen so that the point rests on the underside of the pubic periosteum.
While maintaining contact with the underside of the pubis, the suture passer with the probe tip retracted is thereafter passed distally toward the introitus. At the completion of this distal passage, the suture passer can be palpated through the introitus to the right of the urethra 56. The distal end tip of the suture passer is withdrawn from the surface of the pubourethral ligament and gently swept along the pubocervical fascia to the area of the bladder neck under the guidance of a finger within the vagina. Palpation through the vagina may be safely performed to assist in localization of the suture passer tip.
The probe tip is then distally extended. The suture passer is then passed through the endopelvic fascia and into the pocket 60 between the urethra 56 and the upper vaginal wall 54 at which time the probe tip is retracted. The surgeon then guides the suture passer distally into the vagina through the midline incision 52 in the upper vaginal wall 54. The probe is then retracted maximally to the unlocked position to allow the first end of the suture to be manually removed from the suture channel.
The surgeon selects a sling, such as sling 10 of the present invention. The surgeon secures the suture 36 to a first end portion 14 of the sling by advancing the first end of the suture through the suture receiving site 18 as previously described.
After securing the suture 36 to the first end portion of the sling 10, the first end of the suture is placed into the unlocked suture channel and locked into place. The suture passer and suture locked therein are then pulled up through the suprapubic wound. The first end of the suture is then released from the suture channel by manually retracting the probe.
The identical procedure is performed on the left side.
The surgeon places the sling 10 into the pocket 60 through the midline incision 52 in the upper vaginal wall 54. The sling is placed under the urethra, preferably under the bladderneck, in order to realign the urethra and bladderneck to the correct anatomical position and provide a stable floor to counteract internal stresses.
As will be apparent to one of skill in the art, the sling may be placed beneath the bladderneck in a variety of ways other than via the pocket 60. For instance, an inverted U shaped incision may alternatively be made .18.
beneath the bladderneck. The tissue beneath the inverted U shaped incision may be bluntly dissected to create a flap. The sling may then be inserted in the dissected opening.
After placing the sling in the pocket or opening, the surgeon aligns the sling so that the visual indicator 20 is located directly beneath the urethra 56. As will be apparent to one of skill in the art, alignment of the sling relative to the urethra can be accomplished in a variety of ways, such as by direct visualization.
After the sling 10 is correctly positioned, the first and second ends of the suture on each side are tied to each other with sufficient tension to stabilize and support the bladder neck as illustrated in Figures 11 and 14. The Foley catheter is removed prior to tying the suspensory sutures.
In order to minimize postoperative urinary blockage caused by excessive tension, and minimize postoperative urinary incontinence due to insufficient tension, suture tension is regulated by tying the first and second ends of the sutures across a suture tensioner of a type such as that illustrated in Figures 46-49 of the above incorporated U.S.
Patent No. 5,611,515, issued March 18, 1997 to Benderev et al. The suture tensioner is thereafter removed and the position of the visual indicator 20 relative to the urethra is reconfirmed prior to closing the vaginal and suprapubic wounds.
The wounds are irrigated with an antibiotic solution, such as a bacitracin solution. The wound edges and the rectus fascia at the suture entry points are infiltrated with bupivacaine.
A Foley catheter is introduced.
Alternatively, a suprapubic tube can 6e placed, especially in those patients having dexterity problems or an aversion to learning intermittent catheterization.
Following surgery, the patient is given either ciprofloxacin or ofloxacin for ten days. For those patients having a Foley catheter, the catheter is removed approximately one week following surgery. The patient performs intermittent catheterization as necessary until the post-void residuals are less than 75 cc on two consecutive catheterizations. In patients having a suprapubic tube, the suprapubic tube is removed when the post-void residuals are less than 75 cc following two consecutive urinations.
As will be apparent to one of skill in the art, the foregoing method can be readily modified for use with sling 110 in which the function of the integral attachment members 148 is similar to that of the sutures 36 described above. In addition, while the foregoing procedure was described using two bone anchors per patient, one of ordinary skill in the art will recognize that the procedure could also be accomplished using either one anchor per patient or greater than two anchors per patient. The one anchor embodiment is especially preferred far use with slings having a single suture end or single integral attachment member extending from each end of the sling, such as the sling 110 illustrated in Figure 10B. In those cases where one anchor per patient is used, the anchor is preferably located adjacent to the symphysis pubis. The stings of the present invention can also be suspended from structures other than bone, such as Cooper's ligament or the rectus fascia without using bone anchors.
Although this invention has been described in terms of certain preferred embodiments, other embodiments which will be apparent to those of ordinary skill in the art in view of the disclosure herein are also within the scope of this invention. Accordingly, the scope of the invention is intended to be defined only by reference to the appended claims.
STABILIZATION SLING FOR USE IN
MINIMALLY INVASIVE PELVIC SURGERY
Field of the Invention The present invention relates to slings for use in improving urinary continence. More particularly, the present invention relates to prefabricated urethral stabilization or suspension slings, methods of making the slings and kits including the slings.
Background of the Invention Urinary incontinence is a widespread problem in the United States and throughout the world. Urinary incontinence affects people of all ages and can severely impact a patient both physiologically and psychologically.
In approximately 30% of the women suffering from urinary incontinence, incontinence is caused by intrinsic sphincter deficiency pSDI, a condition in which the valves of the urethral sphincter do not properly coapt. In approximately another 30% of incontinent women, incontinence is caused by hypermobility, a condition in which the muscles around the bladder relax, causing the bladder neck and proximal urethra to rotate and descend in response to increases in intraabdominal pressure. Hypermobility may be the result of pregnancy or other conditions which weaken the muscles. In an additional group of women with urinary incontinence, the condition is caused by a combination of ISD and hypermobility.
In addition to the conditions described above, urinary incontinence has a number of other causes, including birth defects, disease, injury, aging, and urinary tract infection.
Numerous approaches for treating urinary incontinence are available. One such approach involves the use of a sling. At the present time, however, surgeons using a sling based procedure must grow or harvest autologous tissue or purchase processed cadaveric tissue, animal tissue, or synthetic material from a supplier and fashion the sling during the surgical procedure. Thus, during surgery, the surgeon must cut the sling to the desired dimensions and shape, and attach sutures to the sling. in addition to increasing surgical expense, these steps increase the time required for and complexity of the procedure, thereby increasing surgical morbidity and mortality.
In addition, the slings currently in use are susceptible to tearing at the sites where the sutures are attached to the sling. If the suture attachment sites tear, the sling becomes dislodged and incontinence may result. Additional surgery is required to replace the dislodged sling and restore continence.
Thus, there remains a need for a prefabricated sling which overcomes the above deficiencies. U.S. Patent Na. 5,811,515, issued March 18, 1997 to Benderev et al., introduces pioneering minimally invasive percutaneous and transvaginal bladder neck stabilization approaches. The percutaneous approach of Benderev et al. involves stabilizing the bladder neck using a bone anchor which is percutaneously introduced from the abdominal side of the patient.
The transvaginal approach of Benderev et al. involves stabilizing the bladder neck using a staple or bone anchor which is transvaginally placed into the pubic bone. The slings of the present invention may be used in several urethral or bladder neck stabilization procedures, including the minimally invasive percutaneous and transvaginal procedures described below and those described in Benderev et al.
.2.
Summary of the Invention The present invention relates to prefabricated urethra) stabilization slings, methods of making the slings, methods of attaching sutures to the slings, kits comprising the slings, and methods of using the slings to treat urinary incontinence.
One aspect of the invention is a prefabricated sling for improving urinary continence which is made of a biocompatible material and has an elongate shape adapted for urethra) stabilization. The biocompatible material has a central portion extending longitudinally between a first end portion and a second end portion and at least a pair of suture receiving sites which comprise a first site located in the first end portion of the material and a second site located in the second end portion of the material. The first site is adapted for receiving at least a first suture and the second site is adapted for receiving at least a second suture. The first site and the second site are generally disposed along a line extending longitudinally relative to the sling.
In one embodiment of the sling, the biocompatible material is directionally oriented. For example, the biocompatible directionally oriented material may be longitudinally oriented.
In a further embodiment, the first and second end portions of the directionally oriented material have at Least one presewn edge and are generally at least twice as thick as the central portion. In yet another embodiment, the first and second suture receiving sites have an inner diameter at least equal to the diameter of the sutures.
In a further embodiment of the sling, the biocompatible material is absorbable. In some embodiments of the sling, the biocompatible material is woven.
In yet another embodiment of the sling, the biocompatible material is coated.
In some embodiments, the coating on the biocompatible material is absorbed after implantation to facilitate tissue ingrowth into the biocompatible material.
In another embodiment of the sling, the biocompatible material is impregnated with an antibiotic. In one embodiment, the sling is impregnated with bacitracin. In another embodiment, the sling is impregnated with polymixim. In another embodiment the sling is impregnated with neomycin.
in some embodiments, the sling is capable of releasing a drug. in further embodiments, the drug is released over time.
The sting may have a visual indicator for indicating the position of the sling relative to the urethra. The visual indicator may comprise at least one transversely extending line in the central portion of the material.
In some embodiments, the sling has a stabilizer for further strengthening and further reducing buckling of the sling, the stabilizer being located in the first and second end portions of the sling.
In some embodiments, the material around the periphery of the suture receiving sites is reinforced. In other embodiments, the suture receiving sites are strengthened with a reinforcing device.
Another aspect of the present invention is a prefabricated sling for improving urinary continence comprising a biocompatible material having an elongate shape adapted for urethra) stabilization. In this aspect of the invention, the biocompatible material has a central portion extending longitudinally between a first end portion and a second end portion. In this aspect of the invention, the sling also has integral attachment members for suspending the sling.
Yet another aspect of the present invention is a kit far performing a urethral stabilization. The kit comprises a sterile biocompatible material having an elongate shape adapted for urethral stabilization. The biocompatible material has a central portion extending longitudinally between a first end portion and a second end portion. The biocompatible material also has at least a pair of suture receiving sites. The pair of suture receiving sites comprises a first suture receiving site located in the first end portion of the biocompatible material and a second suture receiving site located in the second end portion of the biocompatible material. The first suture receiving site is adapted for receiving at least a first suture, and the second suture receiving site is adapted for receiving at least a second suture. The first suture receiving site and the second suture receiving site are generally disposed along a line extending longitudinally relative to the sling.
In one embodiment of the kit, the sling is packaged. In another embodiment of the kit, the first and second suture receiving sites are apertures. In still another embodiment of the kit, the biocompatible material has at least a first and a second suture secured thereto. In a further embodiment of the kit, the biocompatible material is filamentous.
In still another embodiment, the filamentous material is collagen coated. In some embodiments of the kit, the sutures are looped through the apertures.
Yet another aspect of the present invention is a method of making a sling for improving urinary continence.
A biocompatible material is cut into an elongate shape adapted for urethral stabilization such that the material has a central portion extending longitudinally between a first end portion and a second end portion. At least a pair of suture receiving sites is formed in the material prior to surgery. The pair of suture receiving sites comprises a first site located in the first end portion of the material and a second site located in the second end portion of the material. The first site is adapted for receiving at least a first suture and the second site is adapted for receiving at least a second suture. The first site and the second site are generally disposed along a line extending longitudinally relative to the sling. In one embodiment, the method further comprises the steps of securing at least a first suture to the first site and securing at least a second suture to the second site. In another embodiment, the method further comprises the step of sterilizing the sling. In yet another embodiment, the method further comprises the step of applying an antibiotic to the sling. In still another embodiment, the method further comprises the step of packaging the sting.
Yet another aspect of the present invention is a method of stabilizing a bladder neck to improve urinary incontinence. In one step of the method, a sling comprising a biocompatible material having an elongate shape adapted for urethral stabilization is provided. The material has a central portion extending longitudinally between a first end portion and a second end portion. The sling also comprises at least a pair of suture receiving sites. In another step of the method, a suture is secured to a bone anchor. In another step of the method, the anchor is positioned in a pubic bone. In yet another step of the method, the suture is secured to at least one of the suture receiving sites in the sling. The suture receiving sites are adapted for receiving at least one suture. The suture receiving sites comprise a first suture receiving site located in the first end portion of the material and a second suture receiving site located in the second end portion of the material. The first suture receiving site is adapted for receiving at least a first suture and the second suture receiving site is adapted for receiving at least a second suture.
The first suture receiving site and the second suture receiving site are generally disposed along a line extending longitudinally relative to the sting. In another step of the method, the bladder neck is stabilized with the sling. In one embodiment, the method further comprises introducing the sling percutaneously. In another embodiment of the method, the sling is introduced without invasive surgery.
Brief Description of the Drawines Figure 1 is a plan view of a preferred embodiment of the sling of the present invention.
Figure 2A is a plan view of a parallelogram shaped embodiment of the sling of the present invention.
Figure 2B is a plan view of a hexagonal shaped embodiment of the sling of the present invention.
Figure 2C is a plan view of a rectangular shaped embodiment of the sling of the present invention.
Figure 3A is a plan view of a preferred embodiment of the sling of the present invention showing preferred dimensions.
Figure 38 is a cross-sectional view of the sling taken along line 3B-3B of Figure 3A.
Figure 4A is a partial top view of an end portion of a sling having a single suture receiving site.
Figure 4B is a partial top view of a rounded end portion of a sling having two suture receiving sites.
Figure 4C is a partial top view of an end portion of a sling having three suture receiving sites.
Figure 5A is an enlarged top view of an end portion of a sling in which the suture receiving site is an aperture.
Figure 5B is a cross-sectional view of the end portion taken along line 5B-5B
of Figure 5A.
Figure 5C is an enlarged top view of an end portion of a sling having a reinforcing device in the suture receiving site.
Figure 5D is a cross-sectional view of the end portion taken along line 5D-5D
of Figure 5C.
Figure 5E is an enlarged top view of an end portion of a sling having an alternative reinforcing device in the suture receiving site.
Figure 5F is a cross-sectional view of the end portion taken along line 5F-5F
of Figure 5E.
Figure 5G is an enlarged top view of an end portion of a sling having reinforced material around the periphery of the suture receiving site.
Figure 5H is a cross-sectional view of the end portion taken along line 5H-5H
of Figure 5G.
Figure 51 is an enlarged top view of an end portion of a sling having reinforced material around an alternative suture receiving site.
Figure 5J is a cross-sectional view of the end portion taken along line 5J-5J
of Figure 51.
Figure 5K is an enlarged top view of an end portion of a sling in which the suture receiving site is an aperture and the material around the periphery of the suture receiving site has been reinforced by heat seating or ultrasonically sealing.
Figure 5L is a cross-sectional view of the end portion taken along line 5L-5L
of Figure 5K.
Figure 6A is a plan view of an unfolded parallelogram shaped piece of biocompatible material.
.5. _ Figure 6B is a plan view of a hexagonal shaped piece of material obtained by folding the material of Figure 6A as indicated by the arrows in Figure 6A.
Figure 6C is a plan view of a hexagonal shaped sling in which apertures have been formed as suture receiving sites in the end portions of the sling.
Figure 6D is a cross-sectional view of the hexagonal shaped sling taken along line 6D-6D of Figure 6C.
Figure 6E is the cross-sectional view of Figure 6D showing sutures secured to the apertures of the sling.
Figure 6F is a plan view of an unfolded rectangular shaped piece of biocompatible material.
Figure 6G is a plan view of a rectangular shaped piece of material obtained by folding the material of Figure 6F as indicated by the arrows in Figure 6F.
Figure 6H is a plan view of a rectangular sling in which apertures have been formed as suture receiving sites in the end portions of the sling.
Figure 61 is a crass-sectional view of the rectangular shaped sling taken along line 61-61 of Figure 6H.
Figure 6J is the cross-sectional view of Figure 61 showing sutures secured to the apertures of the sling.
Figure 6K is a plan view of an unfolded rectangular piece of biocompatible material.
Figure 6L is a plan view of a parallelogram shaped piece of material obtained by folding the material of Figure 6K as indicated by the arrows in Figure 6K.
Figure 6M is a plan view of a parallelogram shaped sling in which apertures have been formed as suture receiving sites in the end portions of the sling.
Figure 6N is a cross-sectional view of the parallelogram shaped sling taken along fine 6N-6N of Figure 6M.
Figure 60 is the cross-sectional view of Figure 6N showing sutures secured to the apertures of the sling.
Figure 7A is a schematic plan view of a paralletogram shaped piece of biocompatible material having longitudinally oriented filaments, grains, striations, or polymeric chains.
Figure 7B is a cross-sectional view of the material taken along line 7B-7B of Figure 7A.
Figure 7C is an enlarged view of the material taken along line 7C-7C of Figure 7A.
Figure 7D is an enlarged schematic view of biocompatible material having transversely oriented filaments, grains, striations, or polymeric chains. .
Figure 7E is an enlarged schematic view of biocompatible material having diagonally oriented filaments, grains, striations, or polymeric chains.
Figure 7F is a schematic plan view of a hexagonal shaped sling obtained by folding the material of Figure 7A as indicted by the arrows in Figure 7A and forming apertures as suture receiving sites in the end portions of the sling.
Figure 7G is an enlarged top view of the sling taken along line 7G-7G of Figure 7F showing the filaments, grains, striations, or polymeric chains in an upper layer of an end portion of the sling crossing the filaments, grains, striations, or polymeric chains in the underlying layer.
Figure 8A is an enlarged top view of an end portion of a sling having a suture tooped through a plurality of suture receiving sites.
Figure 8B is a cross-sectional view of the sling taken along line 8B-8B of Figure 8A.
Figure 8C is an enlarged top view of an end portion of a sling having a suture threaded through a suture .
receiving site.
Figure 8D is a cross-sectional view of the sling taken along line 8D-8D of Figure 8C.
Figure 8E is an enlarged top view of an end portion of a sling showing a suture looped around the suture receiving site and an edge of the sling.
Figure 8F is a cross-sectional view of the sling taken along line 8F-8F of Figure 8E.
Figure 9A is a plan view of an end portion of a sling having a stabilizer attached thereto.
Figure 9B is a cross-sectional view of the sting taken along line 9B-9B of Figure 9A.
Figure 9C is a plan view of an end portion of a sling having a stabilizer between the suture receiving sites.
Figure 9D is a cross-sectional view of the sling taken along line 9D-9D of Figure 9C.
Figure 10A is a plan view of a generally rectangular shaped sling with bilaterally extending integral attachment members.
Figure 10B is a plan view of a generally hexagonal shaped sling with bilaterally extending integral attachment members.
Figure 11 is a sagittal section of a female pelvis illustrating the location of the sling of the present invention relative to the bladder neck and the pubic bone.
Figure 12 is a schematic cross-sectional view taken through the urethra and upper vaginal wall illustrating an incision in the upper vaginal wall.
Figure 13 is a schematic cross-sectional view taken through the urethra and upper vaginal wall illustrating a bilaterally extending pocket created by blunt dissection.
Figure 14 is a schematic view of a sling of the present invention positioned in the pocket of Figure 13, the sling being suspended from sutures secured to a bone anchor implanted in the pubic bone.
Detailed Description of the Preferred Embodiments The present invention relates to prefabricated slings for use in urethral floor reconstruction. More particularly, the slings are useful for improving or maintaining urinary continence such as by suspending, stabilizing andlor slightly compressing the urethra of an incontinent patient. The slings are particularly useful for treating patients suffering from incontinence caused by Intrinsic Sphincter Deficiency (ISD) andlor hypermobility. The slings may also be used to treat other disorders in which stabilization andlor compression of the urethra would be beneficial.
The present slings are designed to be implanted in a patient suffering from incontinence using the medical procedure described in more detail below. During implantation, the sling is preferably positioned beneath the bladder neck so that the urethra extends across the center of the sling. The sting is biased towards the urethra through tension applied to the sling by sutures or other attachment means, which are preferably anchored to the pubic bone.
The resulting bias stabilizes andlor slightly compresses the urethra so that continence is maintained.
.7.
Although urethral slings have previously been used to treat incontinence, the present slings are prefabricated, eliminating the need for the surgeon to prepare them for use during the surgical procedure. The present slings are _ supplied to the physician in shapes and dimensions adapted for urethral stabilization or suspension, eliminating the need for the surgeon to cut the sling material during surgery. In addition, the present slings are provided with suture receiving sites already prepared so that the surgeon need not manufacture them during surgery. The slings may also be provided with reinforced suture receiving sites to reduce the incidence of tearing about the point of suture attachment. Because the surgeon need not fabricate the sling during surgery, the time required for the surgical procedure is reduced.
In some embodiments, the slings are provided with the sutures preattached.
Alternatively, the slings may have preformed integral attachment members which, like the sutures, allow the sling to be suspended from structures such as the pubic bone. In either case, the need for the surgeon to attach sutures to the sling during surgery is eliminated, thereby simplifying the implantation procedure.
The foregoing features of the present invention overcome the above-discussed deficiencies of slings currently in use. By simplifying and shortening the surgical procedure, use of the slings of the present invention results in decreased surgical morbidity and mortality.
Referring to Figure 1, there is disclosed a plan view of a preferred embodiment of the sling 10 of the present invention. The sling of Figure 1 has been cut into a generally elongate shape adapted for urethral stabilization, with a central portion 12 extending between a first end portion 14 and a second end portion 16.
Suture receiving sites 18 are prefabricated in the first and second end portions 14, 16 of the sling 10. The sling preferably also has a visual indicator 20. These and other features of the present invention will be described in more detail below after discussing the materials from which the sling can be constructed.
The sling may be fabricated from any of a variety of synthetic or naturally occurring biocompatible materials. Such materials may be filamentous or non-filamentous, elastic or inelastic, and may be porous, microporous, perforated, or impermeable. The properties of the sling may be selected as appropriate based on the surgical procedure used to implant the sling and the application for which the sling is used.
Filamentous materials suitable for use in the slings of the present invention include cadaveric or animal tissue such as fascia Iota, rectus fascia or processed coNagen. Synthetic materials such as polyester, polyurethane, or nylon can also be used. The synthetic filamentous material can be woven or non-woven. Filaments made from synthetic materials may be braided together to form strands or threads which can be braided or woven together to form strips of fabric. Preferably, the synthetic filamentous material is polyester.
Non-filamentous materials suitable for use in the slings of the present invention include silicone, polytetrafluoroethylene (PTFEI, polyethylene terephthalate (PET), PTFE, FEP, or thin films such as latex.
As will be apparent to one skilled in the art, the elasticity of the sling material may also be selected based on the type of surgical procedure for which the sling is being used. A
suitable elastic material is knitted polyester.
.8.
As will be apparent to one skilled in the art, inelastic or minimally elastic materials may be preferred for certain procedures such as those in which the sting is used to create an immobile floor. A preferred minimally elastic material is woven polyester.
The porosity of the material may also be selected based on the type of surgical procedure for which the sling is being used. For example, pores, micropores, or perforations permit tissue ingrowth, which is advantageous to stabilize the sling and reduce erosion from constant motion.
Additionally, the sling material may be impregnated with antibiotics or other agents which can be delivered from the surface of the sling as well as through the pores, micropores or perforations. Impregnation with antibiotics or other agents may be facilitated by coating the sling with collagen.
Impermeable materials may also be useful in certain applications of the sling.
Representative impermeable materials include nylons and polyester. A preferred impermeable material is polyester.
A coating may also be applied to the sling. The coating may be used to deliver a number of compounds, such as antibiotics, heparin, immunosuppressant agents or other drugs. In some embodiments, the drug may be released over time. The coating also blocks the interstices of the underlying sling material, thereby decreasing the risk of infection by sequestering the interstices of the sling from contact with microorganisms encountered during implantation of the sling. Preferably, the coating is absorbed after implantation to facilitate tissue ingrowth into the interstices, pores, micropores andlor perforations of the sling material.
Suitable coatings include polyglycolic acid, polylactic acid, blends of polyglycolic acid and polylactic acid, gelatin, polyvinyl alcohol, and polyvinyl pyrrolidone. A preferred coating is a smooth layer of collagen, such as that provided on the Hemashield° woven double velour available from Meadox.
(Meadox Medical, 112 Beaver Drive, Oakland, NJ 07436 or Boston Scientific Corporation, One Boston Scientific Place, Natick, MA 01760.) The smooth collagen coating protects the interstices of the underlying sling material from bacterial contact during implantation, thereby decreasing the risk of infection as previously discussed.
Additionally, the collagen coating facilitates the uptake of antibiotics to reduce the risk of infection as discussed below.
After placement in the body, the collagen is gradually absorbed, facilitating tissue ingrowth into the underlying filamentous mesh. The collagen coating may also enhance tissue compatibility.
The slings of the present invention may also be made of absorbable materials.
Such absorbable slings preferably remain structurally intact for at least three months while supporting tissue ingrowth. Thereafter, the slings may be fully absorbed. Preferably, the stings are fully absorbed over a period of 3-6 months following the three month period in which the sling is intact. Preferably, the absorbable sling is made of polylactic acid or polylactic acidlpolyglycolic acid copolymers.
The slings of the present invention may be fabricated from directionally oriented biocompatible materials.
Such materials include filamentous materials in which the orientation of the filaments is directionally ordered, as well as grained or striated materials in which the grains or striations are directionally ordered. Alternatively, the material may be a polymeric material in which the orientation of the polymeric chains comprising the material is directionally ordered. The polymeric material may or may not be cross-linked.
.g.
The filaments, grains, striations, or polymeric chains in such materials may be oriented in a single direction or may be multidirectional. Suitable directionally oriented materials include synthetic materials such as Trelex° _ Natural Mesh (Meadox Medical, 112 Beaver Drive, Oakland, NJ 07436 or Boston Scientific Corporation, One Boston Scientific Place, Natick, MA 01760.), Hemashield°, and woven and knitted polyester.
Alternatively, the directionally oriented material may be natural material such as grained or striated tissue.
The tissue may be an allograft, xenograft, or autologous tissue. One advantage of autologous tissue is its ability to revascularize and regrow after implantation.
Tissue for use in allografts can be obtained from cadavers. Cadaveric tissue can be harvested according to techniques well known to those skilled in the art and may be selected to minimize the risk of rejection. However, non-cadaveric tissue is generally preferred because of patient preference and the perceived risk of cross-contamination. Although the cadaveric tissue may be absorbed after implantation, the scar tissue which replaces the cadaveric tissue provides support for the bladder neck.
Representative sources of autologous tissue for use in the present slings include striated muscle, fascia Iota, rectus fascia, dura, pericardium and the vaginal wall. The same tissue sources may also be used for allografts.
Typical sources of xenograft tissue include striated muscle, bovine fascia, dura, pericardium and collagen.
In addition to the synthetic and naturally occurring biocompatible materials enumerated above, those ski8ed in the art will appreciate that a variety of other materials may be readily employed in the slings of the present invention.
In addition to the elongate octagonal sling illustrated in Figure 1, the slings of the present invention may be cut into a number of other shapes. For example, several alternative elongate shapes suitable for use in the present invention are shown in Figures 2A-2C. These include parallelograms such as rhomboids (Figure 2AE, hexagons (Figure 2B~, and rectangles (Figure 2C). In addition, the end portion of the sling may be cut into a rounded shape, such as that illustrated in Figure 4B. The optimal shape of the sling is related to anatomical considerations as well as the surgical procedure used to introduce the sling. For instance, slings having rounded ends (Figure 4B) or tapered ends, such as the hexagon (Figure 2B), parallelogram (Figure 2Ah and octagon (Figure 1~, may facilitate insertion into the pocket formed during the surgical procedure discussed in more detail below, since the pocket may not be precisely rectangular.
The optimal dimensions of the sling can be varied considerably to suit particular design criteria desired for a particular application and still embody the present invention. For example, optimal sling dimensions are dependent upon anatomical considerations and the surgical procedure used to introduce and attach the sling. For instance, the optimal length of the sling may be influenced by whether the surgeon prefers to attach a long strip of material to the pubic bone or abdominal musculature with a bone anchor or other securing device. In such procedures, the sting may be up to 30 cm in length and may be 1-5 cm in width. Preferably, the long stings used in such procedures are 15-30 cm in length and 3-5 cm in width. Shorter slings may be preferred for procedures in which the sling is suspended by a suture bridge. Such slings may be 2.5-7cm in length and 1-5cm in width.
The optimal dimensions of the sling may also be influenced by the sling material selected. For instance, the thickness of the sling material may be dependent on the material selected and the strength and tear resistance required for a particular application of the sling.
The dimensions of the preferred embodiment of Figure 1 are shown in Figures 3A
and 3B. The approximate dimensions, in inches, are as follows: A=0.30; B-0.79; C=0.12; D=0.43; F=0.20;
G=0.24; H=0.015; I-0.030;
and J=0.98. Angle E-22~.
As indicated above, the sling 10 is preferably provided with a visual indicator 20. The visual indicator enables the surgeon to position the sling relative to the urethra so that the urethra generally extends across the center of the sling. In one embodiment, the visual indicator 20 comprises two transversely extending dashed lines in the central portion 12 of the sling 10 as illustrated in Figure 1. However, those skilled in the art will recognize that a variety of other types of visual indicators, including radiopaque indicators, could be used in accordance with the present invention.
The sling of the present invention preferably also has at least one suture receiving site formed in both the first and second end portions of the sling. Preferably, the suture receiving site is an aperture. The aperture may be formed by die stamping the sling material ultrasonic cutting, heat cauterizing, or piercing with a hot poker.
Alternatively, the suture receiving site may be sling material as discussed below in regard to Figures 51 and 5J.
The suture receiving site is adapted for receiving at least one suture.
Preferably, the suture receiving site has an inner diameter at least equal to the diameter of the suture to be received therein. In the preferred embodiment depicted in Figure 1, both the first and second end portions of the sling have two apertures which are equally displaced from the central longitudinal axis of the sling. However, numerous alternative embodiments are also contemplated by the present invention.
For example, some embodiments of the sling, such as that depicted in Figure 4A, have only one suture receiving site formed per end portion. In such embodiments, the suture receiving site 18 is preferably located along the central longitudinal axis 19 of the sling.
Other embodiments of the sling have 3 or more suture receiving sites formed per end portion. In such embodiments, preferably at least one suture receiving site 18 is located along the central longitudinal axis 19 of the sling with the other suture receiving sites 18 being located symmetrically about the central longitudinal axis 19 as illustrated in Figure 4C.
Preferably, in embodiments in which the number of suture receiving sites in each end portion of the sling is odd, at least one suture receiving site in each end portion of the sling is located along the central longitudinal axis of the sling as shown in Figures 4A and 4C. In those embodiments in which the number of suture receiving sites in each end portion of the sling is even, the suture receiving sites are preferably disposed symmetrically about the central longitudinal axis of the sling as depicted in Figures 1 and 4B.
The use of a plurality of suture receiving sites in each end portion of the sting results in reduced buckling of the sling after implantation compared to embodiments having a single suture receiving site at each end of the sling. Thus, embodiments having a plurality of suture receiving sites in each end portion are preferred.
Although several examples of the locations and number of he suture receiving sites in the end portions of the present slings have been provided above, those skilled in the art will appreciate that additional configurations fall within the scope of the present invention. It will also be appreciated by those skilled in the art that the various configurations and numbers of suture receiving sites described above may be utilized with any of the sling shapes or biocompatible materials described above.
Figure 5 shows various types of suture receiving sites which may be used in the slings of the present invention. In Figures 5A and 5B, the suture receiving site is an aperture formed in the sling material. This type of suture receiving site is employed in the embodiment shown in Figure 1.
Preferably, the material around the periphery of the suture receiving sites is reinforced by heat sealing or ultrasonic sealing.
In addition, the suture receiving sites can be strengthened in order to minimize the possibility of tearing.
For instance, one piece reinforcing devices may be inserted in the apertures in the sling material. As shown in Figures 5C and 5D, the one piece reinforcing device 22 has an upper rim 24 and a lower rim 26 between which the sling material bordering the suture receiving site is enclosed. Although the upper rim and the lower rim are shown parallel to one another in Figure 5D, alternative embodiments are contemplated in which the upper and lower rims converge towards each other with the sling material therebetween. The upper rim and the lower rim may also be provided with friction enhancing retention structures to minimize the risk of dislodgement of the one piece reinforcing device. Preferably, the one piece reinforcing device 22 is fabricated from biocompatible plastics or metals, such as stainless steel or titanium.
Alternatively, the area around an aperture 18 in the sling material may be strengthened by inserting a multiple piece reinforcing device 28 therein. As illustrated in Figures 5E and 5F, the multiple piece reinforcing device 28 has a first piece 30 and a second piece 32, which interlock and enclose the sling material bordering the suture receiving site. Although the first piece and the second piece are shown parallel to one another in Figure 5F, alternative embodiments are contemplated in which they converge towards each other as discussed above with respect to the one piece reinforcing device. The first piece and the second piece may also be provided with friction enhancing retention structures to minimize the risk of dislodgement of the multiple piece reinforcing device.
Preferably, the multiple piece reinforcing device 28 is fabricated from biocompatible plastics or metals, such as stainless steel or titanium.
Yet another way of reducing the risk of tearing comprises reinforcing the sling material around the periphery of the suture receiving sites. Slings having such reinforced material around the periphery of the suture receiving site are depicted schematically in Figures 5G through 5J. In Figures 5G and 5H, the suture receiving site is an aperture.
In Figures 51 and 5J, the suture receiving site comprises sling material. In the embodiment of Figures 51 and 5J, the sling material at the suture receiving site provides a puncture target into which the surgeon can insert the suspending suture. In Figures 5K and 5L the suture receiving site is an aperture and the periphery of the suture receiving site is reinforced by heat sealing or ultrasonically sealing.
Preferably, the material around the periphery of the suture receiving sites is reinforced by heat sealing or ultrasonic sealing. The reinforced material 34 around the periphery of the suture receiving site shown in Figures 5G through 5L may be formed in a variety of ways, such .12.
as by heat sealing, ultrasonically sealing, or sewing the area of the sling material along the periphery of the suture receiving site.
In further embodiments of the present invention, the periphery of the suture receiving sites is strengthened by making the end portions of the sling thicker than the central portion as shown in Figures 6A-60. One way to fabricate slings in which the end portions are thicker than the central portion is to fold the end portions of the sling.
For example, a hexagonal shaped piece of material, shown in Figure 6B, may be formed by folding the parallelogram shaped piece of biocompatible material shown in Figure 6A along the lines indicated in Figure 6A. Alternatively, the hexagonal material of Figure 6B may be formed by folding a trapezoidal piece of material, as will be apparent to one skilled in the art. Suture receiving sites may be formed in the hexagonal shaped intermediate of Figure 6B to form the hexagonal shaped sling of Figure 6C, in which the end portions 14, 16 are generally twice the thickness of the central portion 12 of the sling. A cross-sectional view of the hexagonal shaped sling depicting the double thickness end portions is shown in Figure 6D. Figure 6E illustrates a suture 36 secured in the suture receiving site 18. The suture can be secured to the suture receiving site during the manufacturing process of the sling or by the physician prior to or during surgery.
In another embodiment, a rectangular piece of material, shown in Figure 6G, may be formed by folding the rectangular piece of biocompatible material shown in Figure 6F along the lines indicated in Figure 6F. Suture receiving sites may be formed in the rectangular shaped intermediate of Figure 6G to form the rectangular sling of Figure 6H, in which the end portions 14, 16 are generally twice the thickness of the central portion 12 of the sling.
A cross-sectional view of the rectangular shaped sling depicting the double thickness end portions is shown in Figure 61. Figure 6J illustrates a suture 36 secured in the suture receiving site 18 as discussed above with regard to Figure 6E.
In a further embodiment, a rhomboid shaped piece of material, shown in Figure 6L, may be formed by folding the rectangular piece of biocompatible material shown in Figure 6K
along the lines indicated in Figure 6K.
Suture receiving sites may be formed in the rhomboid shaped intermediate of Figure 6L to form the rhomboid shaped sling of Figure 6M, in which the end portions 14, 16 are generally twice the thickness of the central portion 12 of the sling. A cross-sectional view of the rhomboid shaped sling depicting the double thickness end portions is shown in Figure 6N. Figure 60 illustrates a suture 36 secured in the suture receiving site 18 as discussed above with regard to Figures 6E and 6J.
Those skilled in the art will appreciate that slings in which the end portions are thicker than the central portion may be made in any of the shapes and configurations disclosed herein and are not limited to the shapes illustrated in Figures 6A-60.
In some embodiments of the present invention, at least one edge 38, 40, 42 or 44 of each double thickness end portion 14, 16 is secured to an adjacent layer of the sling either during manufacturing of the sling or by the physician prior to or during the surgical procedure. Alternatively, the sling may be supplied to the surgeon with at least one edge 38, 40, 42 or 44 of each double thickness end portion 14, 16 already secured. Preferably, the edge 38 closest to the central portion 12 is sewn. More preferably, all edges 38, 40, 42 and 44 are secured. In those embodiments in which the sting is made from natural tissue, the edge 42 where the fold was made is preferably not secured, although the other edges 38, 40 andlor 44 of the double thickness end portions may be secured. Numerous methods familiar to those skilled in the art may be used to secure the edges, such as sewing, heat sealing, ultrasonic sealing, stapling or gluing. Preferably, the edges are secured by sewing during the manufacturing process or prior to surgery, and by sewing, stapling or gluing during the surgical procedure.
As will be apparent to one of skill in the art, slings having end portions that are thicker than the central portion can be made in a variety of ways other than those described above. For example, the sling material may be folded over on itself more than once to produce slings with end portions more than twice as thick as the central portion. Alternatively, an additional layer or layers of separately cut material could be secured to the end portions of the sling, thereby producing a sting having end portions of varying thickness. Slings having two or more layers of material in both the end portions and the central portion are also contemplated. Such slings can be formed by securing the upper layer or layers of sling material to the lower layer or layers using the methods discussed above.
In addition to the resistance to tearing provided by slings in which the suture receiving sites are located in end portions that are thicker than the central portion, a further benefit is provided by securing the upper layer of the vertical edge 38 to the lower layer of the sling. In particular, the secured vertical edge 38 acts as a reinforcing rib which reduces buckling of the sling when the sling is placed under tension after implantation in the patient.
If the suture receiving sites are strengthened using the one piece reinforcement devices, two piece reinforcement devices, or reinforced material around their periphery as described above, the edges 40, 42, 44 of the double thickness end portions of the sling may be secured. The vertical edge 38, however, may be secured to reduce buckling as described above.
Yet a further advantage is provided by forming end portions having double thickness in slings made of directionally oriented materials such as the materials shown in Figures 7A-7G
. The directionally ordered filaments, grains, striations or polymeric chains may be oriented in a variety of directions. For example, Figures 7C-7E illustrate enlarged views of sling materials having longitudinally (Fig. 7C1, transversely (Fig. 7D1, and diagonally (Fig. 7E) oriented filaments, grains, striations or polymeric chains 46, all of.which are suitable for use in the present invention.
Figure 7B is a schematic view of grained materials suitable for use with the present invention. Those skilled in the art will appreciate that the grained materials may have ridges or grooves therein, or may have a smooth surface.
Materials having multidirectional filaments, grains, striations or polymeric chains are also suitable for use in the present invention.
The parallelogram or rhomboid shaped material of Figure 7A can be folded along the indicated lines to form the hexagonal shaped sling having double thickness end portions shown in Figure 7F as described above with regard to Figures 6A-6E. As can be seen in Figures 7F and 7G, when the directionally oriented material is folded over on itself, the filaments, grains, striations or polymeric chains in the upper layer of the double thickness end portion cross the filaments, grains, striations or polymeric chains in the lower layer of the end portion. This nonparallel orientation of the layers of the material relative to each other provides additional protection against tearing in the regions of the sling surrounding the suture receiving sites by having the strength of the grain perpendicular to the suture pull direction.
Slings having two or more layers of directionally oriented material in both the end portions and the central portion, wherein the filaments, grains, striations or polymeric chains in the different layers cross are also contemplated.
In another embodiment, the slings may have a stabilizer attached to the end portions 14, 16 to reduce buckling of the sling 10 and to provide additional strength to the sling 10, as depicted in Figures 9A-9D. Preferably, the stabilizer is made of metal or plastic. The stabilizer may be attached to the sling in a variety of manners such as sewing, heat sealing, mechanical securement, or capturing the stabilizer between a fold in the sling material. In some embodiments, the stabilizer may also be provided with friction enhancing retention structures to minimize the risk of dislodgement of the stabilizer.
In one embodiment, the stabilizer may be attached to an edge at each end of the sling as illustrated in Figures 9A and 9B. The stabilizer may comprise a first side 68, a second side 70, and an intermediate section 72 disposed between the first side 68 and the second side 70. In this embodiment, the stabilizer preferably contacts both sides of the sling 10.
In an alternate embodiment, the stabilizer may comprise a single section 73 which is disposed between the suture receiving sites 18 and is attached to one side of the sling as illustrated in Figures 9C and 9D.
Those skilled in the art will appreciate that additional stabilizer designs and locations are possible. For example, a stabilizer which is located at each end of the sling may contact a single side of the sling 10. In other embodiments, the sling may have one or more stabilizers in the central portion 12 in addition to the stabilizers in the end portions 14, 16. In addition, those skilled in the art will appreciate that the stabilizers may be used in conjunction with any of the sling embodiments described herein.
As previously discussed, the slings can be supplied to the surgeon with the sutures preattached or the sutures can be attached to the suture receiving sites by the surgeon. In either case, a variety of suture attachment methods are contemplated by the present invention.
For example, Figure 8A shows an enlarged top view of an end portion of a sling having two suture receiving sites 18 with a suture 36 secured thereto. In this embodiment, the suture 36 is looped through the suture receiving sites 18, as illustrated in the cross-sectional view of Figure 8B.
Alternatively, the suture can be threaded through one suture receiving site and out the other suture receiving site without looping through the sling material therebetween.
Alternatively, the suture 36 can be threaded through a single suture receiving site 18 as illustrated in Figures 8C and 8D.
Another method of attaching the suture to the sling is illustrated in Figures 8E and BF. In accordance with this method, the suture 36 is looped around the suture receiving site 18 and the edge of the sling.
While Figures SA-8E show a variety of methods for attaching the suture to the sling, those skilled in the art will appreciate that other methods may also be used.
- WO 98/35b32 PCT/US98/030bb .15.
Yet another method of attaching the suture 36 utilizes a connector to link the suture to the sling. Suitable connectors for linking the suture to the sling are disclosed in the copending U.S. Patent Application entitled "Method and Apparatus for Minimally Invasive Pelvic Surgery," (11ESITEC.028A), filed February 13, 1998 and the identically titled U.S. Provisional Patent Application Serial Ne. 60)038,380 filed February 13, 1997. In such embodiments, the sling has a ring member therein to permit the connector to be attached to the sling. Ring members suitable for attaching the connector are also disclosed in the copending U.S. Patent Application entitled "Method and Apparatus for Minimally Invasive Pelvic Surgery," filed simultaneously herewith and the identically titled U.S. Provisional Patent Application Serial No. 601038,380 filed February 13, 1997.
Those skilled in the art will appreciate that a variety of other suture attachment methods can be used in accordance with the present invention.
The present invention also includes prefabricated slings having integral attachment members 148. Such slings can be die cut or ultrasonically cut out of a solid sheet of biocompatible material. Preferably, the slings having integral attachment members are cut from one length of material and the edges are heat sealed. Alternatively, the integral attachment members may comprise trailing filaments such as longer strands in a woven sling. In a further embodiment, the integral attachment members comprise filaments interwoven through the sling material. The function of the integral attachment members 148 is similar to that of the sutures 36, which allow the surgeon to suspend the sling from a structure, such as the pubic bone as described in more detail below.
Representative examples of slings having integral attachment members are depicted in Figures 10A and 108.
Figure 10A shows a generally rectangular shaped sling 110 in which bilaterally extending integral attachment members 148 are formed from the same piece of material as the sling. Figure 108 shows a generally hexagonal shaped sling 110 in which bilaterally extending integral attachment members 148 are formed from the same piece of material as the sling. Those skilled in the art will appreciate that slings with integral attachment members having configurations other than those shown in Figures i0A and tOB are also contemplated by the present invention.
The slings of the present invention may be individually packaged andlor sterilized prior to purchase. The packaging may protect the sling during storage. For example, in embodiments in which the sling material comprises a collagen coated filamentous material, the packaging may protect the sling from damage by ultraviolet light. The sling may be soaked in an antibiotic solution, such as a solution of neomycin, bacitracin, or polymixim, to prevent microorganisms from collecting on and colonizing the surface of the sling during manipulation, thereby reducing the risk of infection following implantation of the sling. The sting may also be sterilized by ethylene oxide or irradiation.
Uptake and delivery of the antibiotic may be enhanced by using a coated sting as described above.
In embodiments in which the sling is made of natural tissue, the sling may be stored in glutaraldehyde or freeze dried. Prior to use in the surgical procedure, the natural tissue may be preconditioned by soaking the sling in a saline solution, such as any standard commercially available saline solution.
The present invention also includes a stabilization sting kit for maintaining urinary continence. Preferably, the kit comprises a prepackaged sling. More preferably, the kit comprises a sterilized sling. In one embodiment, the kit includes a sling having sutures secured thereto. Alternatively, the sling included in the kit may have integral attachment members as described above.
A minimally invasive percutaneous method of sling delivery and stabilization to treat an incontinent patient will now be described with reference to Figures 11 - 14. Preoperatively, the patient receives broad spectrum antibiotics, such as gentamicin and ampicillin. The patient is placed in the dorsal lithotomy position and regional or general anesthesia is administered. Preparation of the patient emphasizes isolation of the anus with a stapled towel or plastic drape. A Foley catheter is placed.
An approximately 1-2 centimeter midline incision 52 is made in the upper vaginal wall 54 beneath the bladderneck, such as at the urethro-vesical junction, as illustrated in Figure 12. The surgeon then inserts an instrument such as surgical scissors through the incision in the upper vaginal wall and bluntly dissects the tissue 58 on both sides of the urethra 56 to create a bilaterally extending pocket 60, which is illustrated in Figure 13.
The bilaterally extending pocket can also be created and the sling can be inserted using a variety of other minimally invasive instrumentslmethods including the transvaginal, hiatal and percutaneous approaches disclosed in the copending U.S. Patent Application entitled "Transvaginal Anchor Implantation Device," Serial No. 081744439 filed November 8, 1996, the copending U.S. Patent Application entitled "Percutaneous and Hiatal Devices and Methods for Use in Minimally Invasive Pelvic Surgery" (VESITEC.029A1. filed February 13, 1998, the identically titled U.S. Provisional Patent Application Serial No. 601038,171, filed February 13, 1997, the copending U.S. Patent Application entitled "Method and Apparatus for Minimally Invasive Pelvic Surgery" (VESITEC.028A), filed February 13, 1998, and the identically titled U.S. Provisional Patent Application Serial No. 601038,380, filed February 13, 1997.
For example, these other approaches may be employed when the physician desires to attach a long strip of material to the pubic bone or other structures such as the abdominal musculature with a bone anchor or other securing device. In such approaches, an opening capable of accommodating the long strip of material is created in the body tissue, the sling is introduced into the opening in the body tissue, and the sling is attached directly or indirectly to the pubic bone or other structures such as the abdominal musculature.
Either before or after creating the pocket 60, a bone~anchor 62, such as a screw in anchor, a push in anchor, or a punch in anchor, is introduced into the pubic bone 64 for fixation of suspensory sutures, with or without pre-drilling a hole in the pubic bone. For instance, the bone anchor is introduced using a bone anchor implantation device of a type such as that illustrated in Figures 15-19 of copending U.S.
Application Serial No. 081385,897, filed February 9, 1995. Bone anchor sites are located by placing the bone anchor implantation device on the body over the area of the pubic bone after visualization or digital palpation over the bone. The surgeon then extends the bone probes distally until both probes have made contact with the pubic bone.
Preferably, one anchor 62 for each side (two per patient) is implanted into the tubercle portions of the pubic bone 64 (approximately two centimeters lateral to the symphysis pubisl. Preferably, the eyelet of the anchor is recessed below the surface of the bone or flush with the surface of the bone. The anchor 62 preferably has a suture 36 slidably secured thereto prior to - WO 98/35632 PCT/~JS98/03066 .17.
implantation of the anchor into the pubic bone so that a first suture end and a second suture end extend from the implanted anchor after removal of the anchor driver.
Two separated approximately one inch transverse incisions are made over the pubic bone as illustrated in the U.S. Patent No. 5,611,515, issued March 18, 1997 to Benderev et al., and dissection is carried down to the area of the rectus fascia. The first end of the anchored suture is manually placed into a suture channel of a suture passer of a type such as that illustrated in Figures 45 and 45a of the above incorporated U.S. Patent No.
5,611,515, issued March 18, 1997 to Benderev et al. The probe is moved distally to lock the suture therein.
Beginning on the right side, the suprapubic wound is stretched cephalad to allow the vertical passage of the suture passer through the rectus fascia with the probe tip fully exposed.
Distal advancement of the suture passer is accomplished with the tip proximally retracted within the probe guide. The suture passer is acutely angled into the abdomen so that the point rests on the underside of the pubic periosteum.
While maintaining contact with the underside of the pubis, the suture passer with the probe tip retracted is thereafter passed distally toward the introitus. At the completion of this distal passage, the suture passer can be palpated through the introitus to the right of the urethra 56. The distal end tip of the suture passer is withdrawn from the surface of the pubourethral ligament and gently swept along the pubocervical fascia to the area of the bladder neck under the guidance of a finger within the vagina. Palpation through the vagina may be safely performed to assist in localization of the suture passer tip.
The probe tip is then distally extended. The suture passer is then passed through the endopelvic fascia and into the pocket 60 between the urethra 56 and the upper vaginal wall 54 at which time the probe tip is retracted. The surgeon then guides the suture passer distally into the vagina through the midline incision 52 in the upper vaginal wall 54. The probe is then retracted maximally to the unlocked position to allow the first end of the suture to be manually removed from the suture channel.
The surgeon selects a sling, such as sling 10 of the present invention. The surgeon secures the suture 36 to a first end portion 14 of the sling by advancing the first end of the suture through the suture receiving site 18 as previously described.
After securing the suture 36 to the first end portion of the sling 10, the first end of the suture is placed into the unlocked suture channel and locked into place. The suture passer and suture locked therein are then pulled up through the suprapubic wound. The first end of the suture is then released from the suture channel by manually retracting the probe.
The identical procedure is performed on the left side.
The surgeon places the sling 10 into the pocket 60 through the midline incision 52 in the upper vaginal wall 54. The sling is placed under the urethra, preferably under the bladderneck, in order to realign the urethra and bladderneck to the correct anatomical position and provide a stable floor to counteract internal stresses.
As will be apparent to one of skill in the art, the sling may be placed beneath the bladderneck in a variety of ways other than via the pocket 60. For instance, an inverted U shaped incision may alternatively be made .18.
beneath the bladderneck. The tissue beneath the inverted U shaped incision may be bluntly dissected to create a flap. The sling may then be inserted in the dissected opening.
After placing the sling in the pocket or opening, the surgeon aligns the sling so that the visual indicator 20 is located directly beneath the urethra 56. As will be apparent to one of skill in the art, alignment of the sling relative to the urethra can be accomplished in a variety of ways, such as by direct visualization.
After the sling 10 is correctly positioned, the first and second ends of the suture on each side are tied to each other with sufficient tension to stabilize and support the bladder neck as illustrated in Figures 11 and 14. The Foley catheter is removed prior to tying the suspensory sutures.
In order to minimize postoperative urinary blockage caused by excessive tension, and minimize postoperative urinary incontinence due to insufficient tension, suture tension is regulated by tying the first and second ends of the sutures across a suture tensioner of a type such as that illustrated in Figures 46-49 of the above incorporated U.S.
Patent No. 5,611,515, issued March 18, 1997 to Benderev et al. The suture tensioner is thereafter removed and the position of the visual indicator 20 relative to the urethra is reconfirmed prior to closing the vaginal and suprapubic wounds.
The wounds are irrigated with an antibiotic solution, such as a bacitracin solution. The wound edges and the rectus fascia at the suture entry points are infiltrated with bupivacaine.
A Foley catheter is introduced.
Alternatively, a suprapubic tube can 6e placed, especially in those patients having dexterity problems or an aversion to learning intermittent catheterization.
Following surgery, the patient is given either ciprofloxacin or ofloxacin for ten days. For those patients having a Foley catheter, the catheter is removed approximately one week following surgery. The patient performs intermittent catheterization as necessary until the post-void residuals are less than 75 cc on two consecutive catheterizations. In patients having a suprapubic tube, the suprapubic tube is removed when the post-void residuals are less than 75 cc following two consecutive urinations.
As will be apparent to one of skill in the art, the foregoing method can be readily modified for use with sling 110 in which the function of the integral attachment members 148 is similar to that of the sutures 36 described above. In addition, while the foregoing procedure was described using two bone anchors per patient, one of ordinary skill in the art will recognize that the procedure could also be accomplished using either one anchor per patient or greater than two anchors per patient. The one anchor embodiment is especially preferred far use with slings having a single suture end or single integral attachment member extending from each end of the sling, such as the sling 110 illustrated in Figure 10B. In those cases where one anchor per patient is used, the anchor is preferably located adjacent to the symphysis pubis. The stings of the present invention can also be suspended from structures other than bone, such as Cooper's ligament or the rectus fascia without using bone anchors.
Although this invention has been described in terms of certain preferred embodiments, other embodiments which will be apparent to those of ordinary skill in the art in view of the disclosure herein are also within the scope of this invention. Accordingly, the scope of the invention is intended to be defined only by reference to the appended claims.
Claims (36)
1. A prefabricated sling for improving urinary continence, said sling comprising:
a biocompatible material having an elongate shape adapted for urethral stabilization, said material having a central portion extending longitudinally between a first end portion and a second end portion, said first and second end portions including at least one presewn edge; and at least a pair of suture receiving sites, said pair of suture receiving sites comprising a first site located in said first end portion of said material and a second site located in said second end portion of said material, said first site being adapted for receiving at least a first suture and said second site being adapted for receiving at least a second suture, said first site and said second site being generally disposed along a line extending longitudinally relative to said sling.
a biocompatible material having an elongate shape adapted for urethral stabilization, said material having a central portion extending longitudinally between a first end portion and a second end portion, said first and second end portions including at least one presewn edge; and at least a pair of suture receiving sites, said pair of suture receiving sites comprising a first site located in said first end portion of said material and a second site located in said second end portion of said material, said first site being adapted for receiving at least a first suture and said second site being adapted for receiving at least a second suture, said first site and said second site being generally disposed along a line extending longitudinally relative to said sling.
2. The sling of Claim 1, wherein said biocompatible material is directionally oriented.
3. The sling of Claim 2, wherein said directionally oriented biocompatible material is longitudinally oriented.
4. The sling of Claim 2, wherein said first and second end portions of said directionally oriented material are generally at least twice as thick as said central portion.
5. The sling of Claim 4, wherein said first and second suture receiving sites have an inner diameter at least equal to the diameter of said sutures.
6. The sling of Claim 1, wherein said biocompatible material is absorbable.
7. The sling of Claim 1, wherein said biocompatible material is woven.
8. The sling of Claim 1, wherein said biocompatible material is coated.
9. The sling of Claim 8, wherein the coating on said biocompatible material is absorbed after implantation to facilitate tissue ingrowth into said biocompatible material.
10. The sling of Claim 1, wherein said biocompatible material is impregnated with an antibiotic.
11. The sling of Claim 10, wherein said antibiotic is bacitracin.
12. The sling of Claim 10, wherein said antibiotic is polymixim.
13. The sling of Claim 10, wherein said antibiotic is neomycin.
14. The sling of Claim 1, wherein said sling is capable of releasing a drug.
15. The sling of Claim 14, wherein said drug is released over time.
16. The sling of Claim 1, further comprising a visual indicator for indicating the position of said sling relative to urethra.
17. The sling of Claim 16, wherein said visual indicator comprises at least one transversely extending line in the central portion of said material.
18. The sling of Claim 1 further comprising a stabilizer for further strengthening and further reducing buckling of said sling, said stabilizer being located in said first and second end portions of said sling.
19. The sling of Claim 1, wherein the material around the periphery of said suture receiving sites is reinforced.
20. The sling of Claim 1, wherein said suture receiving sites are strengthened with a reinforcing device.
21. A prefabricated sling for improving urinary continence, said sling comprising:
a biocompatible material having an elongate shape adapted for urethral stabilization, said material having a central portion extending longitudinally between a first end portion and a second end portion, said first and second end portions including at least one presewn edge; and integral attachment members for suspending said sling.
a biocompatible material having an elongate shape adapted for urethral stabilization, said material having a central portion extending longitudinally between a first end portion and a second end portion, said first and second end portions including at least one presewn edge; and integral attachment members for suspending said sling.
22. A kit for performing a urethral stabilization, said kit comprising:
a sterile biocompatible material having an elongate shape adapted for urethral stabilization, said biocompatible material having a central portion extending longitudinally between a first end portion and a second end portion, said first and second end portions including at least one presewn edge; and at least a pair of suture receiving sites, said pair of suture receiving sites comprising a first suture receiving site located in said first end portion of said biocompatible material and a second suture receiving site located in said second end portion of said biocompatible material, said first suture receiving site being adapted for receiving at least a first suture, and said second suture receiving site being adapted for receiving at least a second suture, said first suture receiving site and said second suture receiving site being generally disposed along a line extending longitudinally relative to said sling.
a sterile biocompatible material having an elongate shape adapted for urethral stabilization, said biocompatible material having a central portion extending longitudinally between a first end portion and a second end portion, said first and second end portions including at least one presewn edge; and at least a pair of suture receiving sites, said pair of suture receiving sites comprising a first suture receiving site located in said first end portion of said biocompatible material and a second suture receiving site located in said second end portion of said biocompatible material, said first suture receiving site being adapted for receiving at least a first suture, and said second suture receiving site being adapted for receiving at least a second suture, said first suture receiving site and said second suture receiving site being generally disposed along a line extending longitudinally relative to said sling.
23. The kit of Claim 22, wherein said sling is packaged.
24. The kit of Claim 23, wherein said first and second suture receiving sites are apertures.
25. The kit of Claim 24, wherein said biocompatible material has at least a first and a second suture secured thereto.
26. The kit of Claim 25, wherein said biocompatible material is filamentous.
27. The kit of Claim 26, wherein said filamentous material is collagen coated.
28. The kit of Claim 27, wherein said sutures are looped through said apertures.
29. A method of making a sling for improving urinary continence, comprising:
cutting a biocompatible material into an elongate shape adapted for urethral stabilization such that said material has a central portion extending longitudinally between a first end portion and a second end portion, said first and second end portions including at least one presewn edge; and forming at least a pair of suture receiving sites in said material prior to surgery, said pair of suture receiving sites comprising a first site located in said first end portion of said material and a second site located in said second end portion of said material, said first site being adapted for receiving at least a first suture and said second site being adapted for receiving at least a second suture, said first site and said second site being generally disposed along a line extending longitudinally relative to said sling.
cutting a biocompatible material into an elongate shape adapted for urethral stabilization such that said material has a central portion extending longitudinally between a first end portion and a second end portion, said first and second end portions including at least one presewn edge; and forming at least a pair of suture receiving sites in said material prior to surgery, said pair of suture receiving sites comprising a first site located in said first end portion of said material and a second site located in said second end portion of said material, said first site being adapted for receiving at least a first suture and said second site being adapted for receiving at least a second suture, said first site and said second site being generally disposed along a line extending longitudinally relative to said sling.
30. The method of Claim 29, further comprising the steps of securing at least a first suture to said first site and securing at least a second suture to said second site.
31. The method of Claim 29, further comprising the step of sterilizing said sling.
32. The method of Claim 29, further comprising the step of applying an antibiotic to said sling.
33. The method of Claim 29, further comprising the step of packaging said sling.
34. A method of stabilizing a bladder neck to improve urinary incontinence comprising the steps of:
providing a sling comprising a biocompatible material having an elongate shape adapted for urethral stabilization, said material having a central portion extending longitudinally between a first end portion and a second end portion, said first and second end portions including at least one presewn edge, said sling also comprising at least a pair of suture receiving sites;
securing a suture to a bone anchor;
positioning said anchor in a pubic bone;
securing said suture to at least one of said suture receiving sites in said sling, said suture receiving sites being adapted for receiving at least one suture, said suture receiving sites comprising a first suture receiving site located in said first end portion of said material and a second suture receiving site located in said second end portion of said material, said first suture receiving site being adapted for receiving at least a first suture and said second suture receiving site being adapted for receiving at least a second suture, said first suture receiving site and said second suture receiving site being generally disposed along a line extending longitudinally relative to said sling; and stabilizing said bladder neck with said sling.
providing a sling comprising a biocompatible material having an elongate shape adapted for urethral stabilization, said material having a central portion extending longitudinally between a first end portion and a second end portion, said first and second end portions including at least one presewn edge, said sling also comprising at least a pair of suture receiving sites;
securing a suture to a bone anchor;
positioning said anchor in a pubic bone;
securing said suture to at least one of said suture receiving sites in said sling, said suture receiving sites being adapted for receiving at least one suture, said suture receiving sites comprising a first suture receiving site located in said first end portion of said material and a second suture receiving site located in said second end portion of said material, said first suture receiving site being adapted for receiving at least a first suture and said second suture receiving site being adapted for receiving at least a second suture, said first suture receiving site and said second suture receiving site being generally disposed along a line extending longitudinally relative to said sling; and stabilizing said bladder neck with said sling.
35. The method of Claim 34, further comprising introducing said sling percutaneously.
36. The method of Claim 34, wherein said sling is introduced without invasive surgery.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3837997P | 1997-02-13 | 1997-02-13 | |
US60/038,379 | 1997-02-13 | ||
PCT/US1998/003066 WO1998035632A1 (en) | 1997-02-13 | 1998-02-13 | Stabilization sling for use in minimally invasive pelvic surgery |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2280814A1 true CA2280814A1 (en) | 1998-08-20 |
Family
ID=21899608
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002280814A Abandoned CA2280814A1 (en) | 1997-02-13 | 1998-02-13 | Stabilization sling for use in minimally invasive pelvic surgery |
Country Status (7)
Country | Link |
---|---|
US (1) | US6042534A (en) |
EP (1) | EP0983033B1 (en) |
JP (1) | JP2001511685A (en) |
AU (1) | AU6329598A (en) |
CA (1) | CA2280814A1 (en) |
DE (1) | DE69808614T2 (en) |
WO (1) | WO1998035632A1 (en) |
Families Citing this family (400)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6406480B1 (en) | 1992-11-13 | 2002-06-18 | American Med Syst | Bone anchor inserter with retractable shield |
IL127978A0 (en) | 1999-01-08 | 1999-11-30 | Influence Med Tech Ltd | Incontinence device |
US6635058B2 (en) | 1992-11-13 | 2003-10-21 | Ams Research Corporation | Bone anchor |
US6053935A (en) | 1996-11-08 | 2000-04-25 | Boston Scientific Corporation | Transvaginal anchor implantation device |
EP1017321B1 (en) | 1997-02-13 | 2004-01-14 | Boston Scientific Limited | Percutaneous and hiatal devices for use in minimally invasive pelvic surgery |
DE69808614T2 (en) * | 1997-02-13 | 2003-06-18 | Boston Scient Ltd | STABILIZATION SLING FOR USE IN MINIMALLY INVASIVE PELVIC SURGERY |
EP1006886B1 (en) | 1997-02-13 | 2003-07-09 | Boston Scientific Limited | Dilator for minimally invasive pelvic surgery |
US6599235B2 (en) * | 1997-03-18 | 2003-07-29 | American Medical Systems Inc. | Transvaginal bone anchor implantation device |
US6039686A (en) | 1997-03-18 | 2000-03-21 | Kovac; S. Robert | System and a method for the long term cure of recurrent urinary female incontinence |
US6221005B1 (en) * | 1998-02-17 | 2001-04-24 | Norman I. Bruckner | Pubo-urethral support harness apparatus for percutaneous treatment of female stress urinary incontinence with urethal hypemobility |
US6382214B1 (en) | 1998-04-24 | 2002-05-07 | American Medical Systems, Inc. | Methods and apparatus for correction of urinary and gynecological pathologies including treatment of male incontinence and female cystocele |
WO2000009039A1 (en) * | 1998-08-13 | 2000-02-24 | Contimed, Inc. | Bladder sling |
US6050937A (en) * | 1998-09-21 | 2000-04-18 | Benderev; Theodore V. | Surgical tension/pressure monitor |
US20010004704A1 (en) | 1998-11-02 | 2001-06-21 | Barry N. Gellman | Transvaginal suture spacer devices and methods of use |
FR2785521B1 (en) * | 1998-11-10 | 2001-01-05 | Sofradim Production | SUSPENSION DEVICE FOR THE TREATMENT OF PROLAPSUS AND URINARY INCONTINENCES |
FR2787990B1 (en) * | 1998-12-30 | 2001-04-27 | Medical Res & Man Llc | PROSTHESIS FOR CORRECTING URINARY INCONTINENCE IN WOMEN |
WO2000040158A2 (en) * | 1999-01-08 | 2000-07-13 | Influence Medical Technologies, Ltd. | Surgical tack |
US20050283189A1 (en) * | 1999-03-31 | 2005-12-22 | Rosenblatt Peter L | Systems and methods for soft tissue reconstruction |
FR2792824B1 (en) * | 1999-04-27 | 2001-06-22 | Sofradim Production | DEVICE FOR TREATING PROLAPSUS BY VAGINAL SUSPENSION |
EP1189552B1 (en) * | 1999-04-30 | 2009-04-01 | Uromedica Inc. | Apparatus with an adjustable sling for treatment of urinary stress incontinence |
US7121997B2 (en) | 1999-06-09 | 2006-10-17 | Ethicon, Inc. | Surgical instrument and method for treating female urinary incontinence |
US6273852B1 (en) * | 1999-06-09 | 2001-08-14 | Ethicon, Inc. | Surgical instrument and method for treating female urinary incontinence |
US7226407B2 (en) * | 1999-06-09 | 2007-06-05 | Ethicon, Inc. | Surgical instrument and method for treating female urinary incontinence |
CN100415179C (en) * | 1999-06-09 | 2008-09-03 | 伊西康公司 | Surgical instrument and method for adjusting flexible areal polymer implants |
US6932759B2 (en) | 1999-06-09 | 2005-08-23 | Gene W. Kammerer | Surgical instrument and method for treating female urinary incontinence |
US6174279B1 (en) * | 1999-09-21 | 2001-01-16 | Acorn Cardiovascular, Inc. | Cardiac constraint with tension indicator |
US6306079B1 (en) * | 1999-12-07 | 2001-10-23 | Arnaldo F. Trabucco | Mesh pubovaginal sling |
FR2802798B1 (en) | 1999-12-22 | 2002-02-01 | Promedon S A | PAD STRAP FOR THE TREATMENT OF URINARY INCONTINENCE |
US6368859B1 (en) * | 1999-12-29 | 2002-04-09 | Children's Medical Center Corporation | Methods and compositions for producing a fascial sling |
GB2359256B (en) * | 2000-01-21 | 2004-03-03 | Sofradim Production | Percutaneous device for treating urinary stress incontinence in women using a sub-urethral tape |
US7131943B2 (en) * | 2000-03-09 | 2006-11-07 | Ethicon, Inc. | Surgical instrument and method for treating organ prolapse conditions |
FR2807936B1 (en) * | 2000-04-20 | 2002-08-02 | Sofradim Production | ABDOMINAL WALL REINFORCEMENT FOR THE TREATMENT OF INGUINAL HERNIA BY ANTERIOR VOLTAGE-FREE |
DE10019604C2 (en) * | 2000-04-20 | 2002-06-27 | Ethicon Gmbh | implant |
US6425856B1 (en) | 2000-05-10 | 2002-07-30 | Acorn Cardiovascular, Inc. | Cardiac disease treatment and device |
DE60117977D1 (en) * | 2000-06-05 | 2006-05-11 | Boston Scient Ltd | DEVICES FOR TREATING HARNINE CONTINENCE |
US6951534B2 (en) | 2000-06-13 | 2005-10-04 | Acorn Cardiovascular, Inc. | Cardiac support device |
US6638211B2 (en) | 2000-07-05 | 2003-10-28 | Mentor Corporation | Method for treating urinary incontinence in women and implantable device intended to correct urinary incontinence |
FR2811218B1 (en) | 2000-07-05 | 2003-02-28 | Patrice Suslian | IMPLANTABLE DEVICE FOR CORRECTING URINARY INCONTINENCE |
US6592515B2 (en) | 2000-09-07 | 2003-07-15 | Ams Research Corporation | Implantable article and method |
US7025063B2 (en) | 2000-09-07 | 2006-04-11 | Ams Research Corporation | Coated sling material |
US6702827B1 (en) | 2000-10-06 | 2004-03-09 | American Medical Systems | Sling adjustment and tensioning accessory |
US20060205995A1 (en) | 2000-10-12 | 2006-09-14 | Gyne Ideas Limited | Apparatus and method for treating female urinary incontinence |
US8167785B2 (en) | 2000-10-12 | 2012-05-01 | Coloplast A/S | Urethral support system |
GB0025068D0 (en) * | 2000-10-12 | 2000-11-29 | Browning Healthcare Ltd | Apparatus and method for treating female urinary incontinence |
DE10056169C2 (en) * | 2000-11-13 | 2003-07-03 | Ethicon Gmbh | Implant for holding the female bladder |
WO2002039914A1 (en) | 2000-11-15 | 2002-05-23 | Scimed Life Systems, Inc. | Device and method for treating female urinary incontinence |
US20020128670A1 (en) * | 2000-11-22 | 2002-09-12 | Ulf Ulmsten | Surgical instrument and method for treating female urinary incontinence |
US20110168192A9 (en) * | 2000-12-20 | 2011-07-14 | Eduardo Fierro | Adjustable autofixing sling for treatment of urinary incontinence |
WO2003002027A1 (en) * | 2001-06-27 | 2003-01-09 | Promedon Do Brasil Produtos Medico-Hospitalares Ltda | Adjustable autofixing sling for treatment of urinary incontinence |
US6582443B2 (en) | 2000-12-27 | 2003-06-24 | Ams Research Corporation | Apparatus and methods for enhancing the functional longevity and for facilitating the implantation of medical devices |
US20020161382A1 (en) * | 2001-03-29 | 2002-10-31 | Neisz Johann J. | Implant inserted without bone anchors |
US6612977B2 (en) * | 2001-01-23 | 2003-09-02 | American Medical Systems Inc. | Sling delivery system and method of use |
US7229453B2 (en) * | 2001-01-23 | 2007-06-12 | Ams Research Corporation | Pelvic floor implant system and method of assembly |
US6641525B2 (en) | 2001-01-23 | 2003-11-04 | Ams Research Corporation | Sling assembly with secure and convenient attachment |
US6802807B2 (en) | 2001-01-23 | 2004-10-12 | American Medical Systems, Inc. | Surgical instrument and method |
US20020147382A1 (en) | 2001-01-23 | 2002-10-10 | Neisz Johann J. | Surgical articles and methods |
US7070556B2 (en) * | 2002-03-07 | 2006-07-04 | Ams Research Corporation | Transobturator surgical articles and methods |
US6685626B2 (en) * | 2001-02-02 | 2004-02-03 | Regeneration Technologies, Inc. | Compositions, devices, methods, and kits for induction of adhesions |
JP4298296B2 (en) * | 2001-03-09 | 2009-07-15 | ボストン サイエンティフィック リミテッド | Medical sling |
US9149261B2 (en) | 2001-03-09 | 2015-10-06 | Boston Scientific Scimed, Inc. | Systems, methods and devices relating to delivery of medical implants |
US8915927B2 (en) * | 2001-03-09 | 2014-12-23 | Boston Scientific Scimed, Inc. | Systems, methods and devices relating to delivery of medical implants |
WO2002071953A2 (en) * | 2001-03-09 | 2002-09-19 | Scimed Life Systems, Inc. | System for implanting an implant and method thereof |
US8033983B2 (en) | 2001-03-09 | 2011-10-11 | Boston Scientific Scimed, Inc. | Medical implant |
US20050131393A1 (en) * | 2001-03-09 | 2005-06-16 | Scimed Life Systems, Inc. | Systems, methods and devices relating to delivery of medical implants |
US6551356B2 (en) * | 2001-03-19 | 2003-04-22 | Ethicon, Inc. | Pocketed hernia repair |
AUPR406501A0 (en) * | 2001-03-28 | 2001-04-26 | Kaladelfos, George | Treatment of vault prolapse |
GB0108088D0 (en) | 2001-03-30 | 2001-05-23 | Browning Healthcare Ltd | Surgical implant |
US6595911B2 (en) | 2001-04-03 | 2003-07-22 | Lovuolo Michael | Method and device for anchor implantation and support of bodily structures |
US20020183762A1 (en) * | 2001-06-01 | 2002-12-05 | Ams Research Corporation | Bone anchor inserters and methods |
US6755781B2 (en) * | 2001-07-27 | 2004-06-29 | Scimed Life Systems, Inc. | Medical slings |
US7037255B2 (en) | 2001-07-27 | 2006-05-02 | Ams Research Corporation | Surgical instruments for addressing pelvic disorders |
US7407480B2 (en) * | 2001-07-27 | 2008-08-05 | Ams Research Corporation | Method and apparatus for correction of urinary and gynecological pathologies, including treatment of incontinence cystocele |
DE10138950A1 (en) * | 2001-08-03 | 2003-02-20 | Aesculap Ag & Co Kg | Strip for treating urinary incontinence, especially for women, by implantation in abdomen, is flexible and preferably consists (partly) of resorbable material, e.g. polyvinyl alcohol |
DE20204669U1 (en) * | 2002-03-23 | 2003-08-07 | Aesculap Ag & Co Kg | Strip for treating urinary incontinence, especially for women, by implantation in abdomen, is flexible and preferably consists (partly) of resorbable material, e.g. polyvinyl alcohol |
DE10138955A1 (en) * | 2001-08-03 | 2003-02-20 | Aesculap Ag & Co Kg | Surgical instrument has curved shaft, handle with fastening, pointed shaft ends, locking slide-piece and sprung detents |
DE50207513D1 (en) * | 2001-08-03 | 2006-08-24 | Aesculap Ag & Co Kg | INCONTINENCE BAND FOR THE TREATMENT OF HARNING INCONTINENCE |
US20030046111A1 (en) * | 2001-08-31 | 2003-03-06 | American Medical Systems | System and method for treating pelvic floor disorders |
DE60227676D1 (en) | 2001-09-07 | 2008-08-28 | Mardil Inc | METHOD AND DEVICE FOR EXTERNAL HEART STABILIZATION |
US20040073235A1 (en) * | 2001-10-01 | 2004-04-15 | Lund Robert E. | Surgical article |
US6648921B2 (en) * | 2001-10-03 | 2003-11-18 | Ams Research Corporation | Implantable article |
US7087065B2 (en) * | 2001-10-04 | 2006-08-08 | Ethicon, Inc. | Mesh for pelvic floor repair |
US6666817B2 (en) * | 2001-10-05 | 2003-12-23 | Scimed Life Systems, Inc. | Expandable surgical implants and methods of using them |
US6862480B2 (en) * | 2001-11-29 | 2005-03-01 | Biocontrol Medical Ltd. | Pelvic disorder treatment device |
CN100592899C (en) | 2002-03-01 | 2010-03-03 | 埃蒂康有限公司 | Method and apparatus for treating pelvic organ prolapses in female patients |
US8968178B2 (en) * | 2002-03-07 | 2015-03-03 | Ams Research Corporation | Transobturator surgical articles and methods |
US7357773B2 (en) | 2002-03-07 | 2008-04-15 | Ams Research Corporation | Handle and surgical article |
WO2003075792A1 (en) | 2002-03-07 | 2003-09-18 | Ams Research Corporation | Transobturator surgical articles and methods |
US6911003B2 (en) | 2002-03-07 | 2005-06-28 | Ams Research Corporation | Transobturator surgical articles and methods |
GB2402343B (en) * | 2002-04-11 | 2006-03-15 | Gyne Ideas Ltd | Apparatus for treating female urinary incontinence |
WO2003092546A2 (en) * | 2002-04-30 | 2003-11-13 | Cook Urological Inc. | Sling for supporting tissue |
AU2003234212A1 (en) | 2002-05-07 | 2003-11-11 | Ams Research Corporation | Urethral prosthesis with tensioning member |
AU2003232111B2 (en) * | 2002-05-09 | 2008-10-02 | Covidien Lp | Endoscopic organ retractor and method of using the same |
WO2003094754A1 (en) * | 2002-05-09 | 2003-11-20 | Tyco Healthcare Group Lp | Organ retractor and method of using the same |
ES1058519Y (en) * | 2004-10-06 | 2005-04-01 | Maroto Jesus Romero | MESH FOR THE SURGICAL TREATMENT OF URINARY INCONTINENCE. |
US8016743B2 (en) * | 2002-05-29 | 2011-09-13 | Jesus Romero Maroto | System for the treatment of stress urinary incontinence |
US6682475B2 (en) | 2002-06-11 | 2004-01-27 | Acorn Cardiovascular, Inc. | Tension indicator for cardiac support device and method therefore |
EP1511442B1 (en) * | 2002-06-12 | 2010-01-06 | Boston Scientific Limited | Medical slings |
US8641727B2 (en) | 2002-06-13 | 2014-02-04 | Guided Delivery Systems, Inc. | Devices and methods for heart valve repair |
US9949829B2 (en) | 2002-06-13 | 2018-04-24 | Ancora Heart, Inc. | Delivery devices and methods for heart valve repair |
US6881184B2 (en) * | 2002-07-16 | 2005-04-19 | Stephen M. Zappala | Absorbable pubovaginal sling system and method |
ITFI20020145A1 (en) * | 2002-08-01 | 2004-02-02 | Giulio Nicita | DEVICE FOR THE SURGICAL TREATMENT OF FEMALE PROLAXIS. |
DE60334919D1 (en) | 2002-08-02 | 2010-12-23 | Bard Inc C R | SELF-ANCHORING SLING AND INTRODUCTION SYSTEM |
US7371245B2 (en) * | 2002-08-02 | 2008-05-13 | C R Bard, Inc | Transobturator introducer system for sling suspension system |
US7101381B2 (en) * | 2002-08-02 | 2006-09-05 | C.R. Bard, Inc. | Implantable prosthesis |
US7637384B2 (en) * | 2002-08-09 | 2009-12-29 | Crown Packaging Technology, Inc. | Tamper evident closure with locking band and container therefor |
JP4589867B2 (en) | 2002-08-14 | 2010-12-01 | ボストン サイエンティフィック リミテッド | System and device for delivery of medical implants |
FR2843876B1 (en) | 2002-08-30 | 2004-11-26 | Bernard Bouffier | SURGICAL PROSTHESIS DEVICE FOR THE IMPLANTATION OF A SUPPORT OF A MAMMALIAN BODY |
US20060052670A1 (en) * | 2002-10-04 | 2006-03-09 | Stearns Ralph A | Endoscopic retractor |
US7018381B2 (en) * | 2002-10-18 | 2006-03-28 | Zimmer Technology, Inc. | Apparatus for removing an osteophyte |
US20040078090A1 (en) | 2002-10-18 | 2004-04-22 | Francois Binette | Biocompatible scaffolds with tissue fragments |
US7682392B2 (en) * | 2002-10-30 | 2010-03-23 | Depuy Spine, Inc. | Regenerative implants for stabilizing the spine and devices for attachment of said implants |
EP1565125A4 (en) | 2002-11-15 | 2008-04-02 | Ethicon Inc | Method of surgical repair of vagina damaged by pelvic organ prolapse and prosthetic materials and devices suitable for use therein |
US7771345B1 (en) * | 2002-12-03 | 2010-08-10 | O'donnell Pat D | Surgical instrument for treating female urinary stress incontinence |
US6808486B1 (en) | 2002-12-03 | 2004-10-26 | Pat O'Donnell | Surgical instrument for treating female urinary stress incontinence |
EP1581148B1 (en) | 2002-12-17 | 2010-02-17 | Boston Scientific Limited | Spacer for sling delivery system |
US8562646B2 (en) * | 2002-12-19 | 2013-10-22 | Boston Scientific Scimed, Inc. | Anchoring to soft tissue |
US20040143343A1 (en) * | 2003-01-17 | 2004-07-22 | Grocela Joseph A. | Post-radical prostatectomy continence implant |
US7204801B2 (en) * | 2003-01-17 | 2007-04-17 | Massachusetts General Hospital | Pubovaginal support for treating female urinary incontinence |
US6893222B2 (en) * | 2003-02-10 | 2005-05-17 | United Technologies Corporation | Turbine balancing |
US8197837B2 (en) | 2003-03-07 | 2012-06-12 | Depuy Mitek, Inc. | Method of preparation of bioabsorbable porous reinforced tissue implants and implants thereof |
GB0307082D0 (en) | 2003-03-27 | 2003-04-30 | Gyne Ideas Ltd | Drug delivery device and method |
US7494495B2 (en) | 2003-03-28 | 2009-02-24 | Coloplast A/S | Method and implant for curing cystocele |
FR2852817B1 (en) * | 2003-03-28 | 2006-04-28 | Emmanuel Delorme | IMPLANT FOR THE TREATMENT OF THE RECTOCELE AND DEVICE FOR THE PLACEMENT OF THIS IMPLANT |
AU2004229194B2 (en) * | 2003-03-28 | 2010-06-10 | Analytic Biosurgical Solution Abiss | Implant for treatment of a rectocele and device for placement of said implant |
ITRM20030210A1 (en) * | 2003-04-30 | 2004-11-01 | Mauro Cervigni | PROSTHESIS TO BE USED IN THE PROLASSO SURGICAL THERAPY |
US7497864B2 (en) | 2003-04-30 | 2009-03-03 | Marctec, Llc. | Tissue fastener and methods for using same |
US8226715B2 (en) * | 2003-06-30 | 2012-07-24 | Depuy Mitek, Inc. | Scaffold for connective tissue repair |
US7361138B2 (en) * | 2003-07-31 | 2008-04-22 | Scimed Life Systems, Inc. | Bioabsorbable casing for surgical sling assembly |
US10583220B2 (en) | 2003-08-11 | 2020-03-10 | DePuy Synthes Products, Inc. | Method and apparatus for resurfacing an articular surface |
AU2003904283A0 (en) * | 2003-08-12 | 2003-08-28 | Northern Sydney Area Health Service | An implantable direct cardiac compression device and system |
AU2003259832A1 (en) * | 2003-08-14 | 2005-03-10 | Boston Scientific Limited | Medical slings |
CA2535328A1 (en) * | 2003-08-14 | 2005-03-03 | Boston Scientific Limited | Medical slings |
US8545386B2 (en) | 2003-08-14 | 2013-10-01 | Boston Scientific Scimed, Inc. | Surgical slings |
US20050038452A1 (en) * | 2003-08-14 | 2005-02-17 | Scimed Life Systems, Inc. | Medical slings |
DE602004023314D1 (en) * | 2003-08-14 | 2009-11-05 | Boston Scient Ltd | SURGICAL SLINGS |
US7303525B2 (en) * | 2003-08-22 | 2007-12-04 | Ams Research Corporation | Surgical article and methods for treating female urinary incontinence |
US7235042B2 (en) | 2003-09-16 | 2007-06-26 | Acorn Cardiovascular, Inc. | Apparatus and method for applying cardiac support device |
US7347812B2 (en) * | 2003-09-22 | 2008-03-25 | Ams Research Corporation | Prolapse repair |
US7713187B2 (en) | 2003-10-03 | 2010-05-11 | Boston Scientific Scimed, Inc. | Systems and methods for delivering a medical implant to an anatomical location in a patient |
US20050101834A1 (en) * | 2003-11-10 | 2005-05-12 | Merade Bryon L. | Readily implantable sling |
CA2546376C (en) * | 2003-11-17 | 2013-04-16 | Scimed Life Systems, Inc. | Systems and methods relating to associating a medical implant with a delivery device |
US20050129733A1 (en) * | 2003-12-09 | 2005-06-16 | Milbocker Michael T. | Surgical adhesive and uses therefore |
US11395865B2 (en) | 2004-02-09 | 2022-07-26 | DePuy Synthes Products, Inc. | Scaffolds with viable tissue |
WO2005094741A1 (en) * | 2004-03-30 | 2005-10-13 | Proxy Biomedical Limited | Sling for treatment of urinary stress incontinence and/or pelvic floor prolapse |
DE602005025637D1 (en) * | 2004-03-30 | 2011-02-10 | Proxy Biomedical Ltd | TREATED SURGICAL MESH FROM MONOFILES FIBERS |
US7811222B2 (en) | 2004-04-30 | 2010-10-12 | Ams Research Corporation | Method and apparatus for treating pelvic organ prolapse |
US7351197B2 (en) * | 2004-05-07 | 2008-04-01 | Ams Research Corporation | Method and apparatus for cystocele repair |
US7500945B2 (en) | 2004-04-30 | 2009-03-10 | Ams Research Corporation | Method and apparatus for treating pelvic organ prolapse |
US8047982B2 (en) * | 2004-05-07 | 2011-11-01 | Ethicon, Inc. | Mesh tape with wing-like extensions for treating female urinary incontinence |
US8062206B2 (en) | 2004-05-07 | 2011-11-22 | Ams Research Corporation | Method and apparatus for treatment of vaginal anterior repairs |
FR2870450B1 (en) * | 2004-05-18 | 2007-04-20 | David Jean Marie Nocca | ADJUSTABLE PROSTHETIC STRIP |
GB0411360D0 (en) * | 2004-05-21 | 2004-06-23 | Mpathy Medical Devices Ltd | Implant |
US20050278037A1 (en) * | 2004-06-11 | 2005-12-15 | Analytic Biosurgical Solutions-Abiss | Implant for the treatment of cystocele and rectocele |
EP3087949B1 (en) | 2004-06-14 | 2018-07-25 | Boston Scientific Limited | System relating to implantable supportive slings |
AT413793B (en) * | 2004-08-04 | 2006-06-15 | Bauer Wilhelm Dr | IMPLANT FOR THE TREATMENT OF MALE BRAIN HIC IN INCONTINENCE |
US7527588B2 (en) * | 2004-09-15 | 2009-05-05 | Ethicon, Inc. | System and method for surgical implant placement |
US8500624B2 (en) * | 2004-10-25 | 2013-08-06 | Boston Scientific Scimed, Inc. | Systems and methods for sling delivery and placement |
EP1811903A1 (en) * | 2004-11-08 | 2007-08-01 | Endogun Medical Systems Ltd. | Surgical grafts |
US20060173468A1 (en) * | 2005-01-28 | 2006-08-03 | Marc Simmon | Obturator introducer with snare |
US7481314B2 (en) * | 2005-02-02 | 2009-01-27 | Ethicon, Inc. | Packaging assembly for surgical mesh implants |
AU2012216782B2 (en) * | 2005-02-04 | 2014-08-21 | Boston Scientific Scimed, Inc. | Surgical implants and related methods and systems |
US7722528B2 (en) | 2005-02-04 | 2010-05-25 | Ams Research Corporation | Surgical implants and related methods and systems |
US7914437B2 (en) * | 2005-02-04 | 2011-03-29 | Ams Research Corporation | Transobturator methods for installing sling to treat incontinence, and related devices |
US8096303B2 (en) | 2005-02-08 | 2012-01-17 | Koninklijke Philips Electronics N.V | Airway implants and methods and devices for insertion and retrieval |
US8371307B2 (en) | 2005-02-08 | 2013-02-12 | Koninklijke Philips Electronics N.V. | Methods and devices for the treatment of airway obstruction, sleep apnea and snoring |
EP2756794B1 (en) * | 2005-02-08 | 2019-04-10 | Koninklijke Philips N.V. | System and method for percutaneous glossoplasty |
AU2006226961A1 (en) * | 2005-03-22 | 2006-09-28 | Tyco Healthcare Group, Lp | Mesh implant |
US7556598B2 (en) * | 2005-04-04 | 2009-07-07 | Boston Scientific Scimed, Inc. | Dissolvable protective treatment for an implantable supportive sling |
ES2536748T3 (en) | 2005-04-06 | 2015-05-28 | Boston Scientific Limited | Systems and devices to treat pelvic floor disorders |
US8109866B2 (en) | 2005-04-26 | 2012-02-07 | Ams Research Corporation | Method and apparatus for prolapse repair |
US7393320B2 (en) * | 2005-04-29 | 2008-07-01 | Ams Research Corporation | Pelvic floor health articles and procedures |
US7431690B2 (en) * | 2005-04-30 | 2008-10-07 | Coloplast A/S | Implantable sling for the treatment of male incontinence and method of using the same |
WO2006119273A2 (en) * | 2005-05-04 | 2006-11-09 | Ams Research Corporation | Apparatus for securing and tensioning a urethral sling to public bone |
US8043205B2 (en) | 2005-07-13 | 2011-10-25 | Boston Scientific Scimed, Inc. | Snap fit sling anchor system |
US9248010B2 (en) | 2005-07-15 | 2016-02-02 | Boston Scientific Scimed, Inc. | Tension-adjustable surgical sling assembly |
EP1909691B1 (en) | 2005-07-25 | 2015-09-16 | Boston Scientific Limited | Pelvic floor repair system |
US7981023B2 (en) | 2005-07-25 | 2011-07-19 | Boston Scientific Scimed, Inc. | Elastic sling system and related methods |
CA2615130A1 (en) | 2005-07-26 | 2007-02-08 | Ams Research Corporation | Methods and systems for treatment of prolapse |
WO2007018532A1 (en) * | 2005-08-03 | 2007-02-15 | Boston Scientific Scimed, Inc. | Systems, devices and methods relating to a shape resilient sling-like support for treating urinary incontinence |
US8123671B2 (en) | 2005-08-04 | 2012-02-28 | C.R. Bard, Inc. | Pelvic implant systems and methods |
US7935046B2 (en) | 2005-08-11 | 2011-05-03 | Boston Scientific Scimed, Inc. | Systems, methods and devices relating to a removable sleeve for an implantable sling |
US7951066B2 (en) | 2005-08-17 | 2011-05-31 | Boston Scientific Scimed, Inc. | Medical device positioning assemblies and methods |
US8128552B2 (en) * | 2005-08-22 | 2012-03-06 | O'donnell Pat D | Surgical instrument for treating female pelvic prolapse |
US20080207989A1 (en) * | 2005-08-29 | 2008-08-28 | Ams Research Corporation | System For Positioning Support Mesh in a Patient |
US7699769B2 (en) | 2005-09-01 | 2010-04-20 | Boston Scientific Scimed, Inc. | Adjustable surgical sling |
US7878970B2 (en) | 2005-09-28 | 2011-02-01 | Boston Scientific Scimed, Inc. | Apparatus and method for suspending a uterus |
CA2626014C (en) * | 2005-10-18 | 2012-07-10 | Cook Biotech Incorporated | Medical device with affixation means |
US8186355B2 (en) | 2005-11-09 | 2012-05-29 | Koninklijke Philips Electronics N.V. | Glossoplasty using tissue anchor glossopexy with volumetric tongue reduction |
US8092366B2 (en) | 2005-11-14 | 2012-01-10 | C. R. Bard, Inc. | Sling anchor system |
US7637860B2 (en) * | 2005-11-16 | 2009-12-29 | Boston Scientific Scimed, Inc. | Devices for minimally invasive pelvic surgery |
US9144483B2 (en) * | 2006-01-13 | 2015-09-29 | Boston Scientific Scimed, Inc. | Placing fixation devices |
US7559885B2 (en) * | 2006-02-14 | 2009-07-14 | Coloplast A/S | Implantable sling for the treatment of incontinence and method of using the same |
CA2641789C (en) | 2006-02-16 | 2015-12-22 | Ams Research Corporation | Surgical articles and methods for treating pelvic conditions |
US8195296B2 (en) | 2006-03-03 | 2012-06-05 | Ams Research Corporation | Apparatus for treating stress and urge incontinence |
US20070208217A1 (en) | 2006-03-03 | 2007-09-06 | Acorn Cardiovascular, Inc. | Self-adjusting attachment structure for a cardiac support device |
US8170686B2 (en) * | 2006-03-14 | 2012-05-01 | Boston Scientific Scimed, Inc. | Heatable sling support for an anatomical location |
WO2007106897A2 (en) | 2006-03-15 | 2007-09-20 | Dennis Miller | System and method for treating tissue wall prolapse |
EP1993473A4 (en) * | 2006-03-15 | 2011-01-26 | Bard Inc C R | Implants for the treatment of pelvic floor disorders |
WO2007109508A1 (en) * | 2006-03-16 | 2007-09-27 | Boston Scientific Limited | System and method for treating tissue wall prolapse |
WO2007130953A2 (en) | 2006-05-01 | 2007-11-15 | Duodyn Technology, Llc | Apparatus and method for managing incontinence |
EP2019648A4 (en) * | 2006-05-19 | 2017-06-07 | AMS Research Corporation | Method and articles for treatment of stress urinary incontinence |
US8721519B2 (en) * | 2006-06-06 | 2014-05-13 | Boston Scientific Scimed, Inc. | Implantable mesh combining biodegradable and non-biodegradable fibers |
ES2536086T3 (en) * | 2006-06-08 | 2015-05-20 | Ams Research Corporation | Apparatus for repair of distention of the lifting muscle |
BRPI0712194A2 (en) | 2006-06-16 | 2012-03-06 | Ams Research Corporation | PELVIC AND SURGICAL IMPLANTS COMBINATION USEFUL SURGICAL TOOL TO IMPLEMENT A PELVIC IMPLANT METHODS OF TREATING A PELVIC CONDITION AND VAGINAL PROLAPSE, AND, METHOD FOR HANDLING A SURGICAL IMPLANT |
US20090259092A1 (en) * | 2006-06-22 | 2009-10-15 | Ogdahl Jason W | Adjustable Sling and Method of Treating Pelvic Conditions |
CA2654294C (en) | 2006-06-22 | 2016-09-20 | Ams Research Corporation | Adjustable tension incontinence sling assemblies |
US8617046B2 (en) * | 2006-06-26 | 2013-12-31 | Ams Research Corporation | Floating sling for treatment of incontinence |
US7951065B2 (en) * | 2006-06-26 | 2011-05-31 | Cook Medical Technologies Llc | Tension free pelvic floor repair |
US7828715B2 (en) | 2006-06-29 | 2010-11-09 | Ams Research Corporation | Method of treating anal incontinence |
US8160710B2 (en) | 2006-07-10 | 2012-04-17 | Ams Research Corporation | Systems and methods for implanting tissue stimulation electrodes in the pelvic region |
US7651462B2 (en) | 2006-07-17 | 2010-01-26 | Acorn Cardiovascular, Inc. | Cardiac support device delivery tool with release mechanism |
US8257245B2 (en) * | 2006-07-21 | 2012-09-04 | Specialties Remeex International, S.L. | Adjustable sling as a support of internal organs or anatomical tissues |
BRPI0715092A2 (en) | 2006-07-25 | 2013-06-04 | Ams Res Corp | pelvic implant, kit, and method to use it |
AU2015202101B2 (en) * | 2006-07-25 | 2017-09-14 | Boston Scientific Scimed, Inc. | Surgical articles and methods for treating pelvic conditions |
US8480557B2 (en) | 2006-07-27 | 2013-07-09 | Refine, Llc | Nonaugmentive mastopexy |
CA2659325A1 (en) * | 2006-08-02 | 2008-02-07 | Compagnie De Recherche En Composants, Implants Et Materiels Pour L'appli Cation Clinique | Suburethral hammock |
US8480559B2 (en) | 2006-09-13 | 2013-07-09 | C. R. Bard, Inc. | Urethral support system |
CA2665374C (en) * | 2006-10-03 | 2015-06-02 | Boston Scientific Scimed, Inc. | Pelvic floor repair implants and methods |
WO2008042992A2 (en) | 2006-10-03 | 2008-04-10 | Alure Medical, Inc. | Minimally invasive tissue support |
US9289279B2 (en) * | 2006-10-06 | 2016-03-22 | Promethean Surgical Devices, Llc | Apparatus and method for limiting surgical adhesions |
EP2073752B1 (en) | 2006-10-18 | 2017-12-27 | Coloplast A/S | Implantable devices for the treatment of incontinence |
BRPI0718177A2 (en) * | 2006-10-26 | 2013-12-17 | Ams Res Corp | PELVIC IMPLANT, KIT, AND, METHOD TO USE THE SAME. |
EP2081517A4 (en) | 2006-11-06 | 2017-06-21 | Caldera Medical, Inc. | Implants and procedures for treatment of pelvic floor disorders |
US20110082328A1 (en) * | 2007-01-03 | 2011-04-07 | Christian Gozzi | Methods for installing sling to treat fecal incontinence, and related devices |
US9888924B2 (en) * | 2007-03-06 | 2018-02-13 | Covidien Lp | Wound closure material |
EP2131750B1 (en) * | 2007-03-06 | 2016-05-04 | Covidien LP | Wound closure material |
ATE468827T1 (en) | 2007-03-07 | 2010-06-15 | Assut Europ S P A | PROSTHESIS FOR THE TREATMENT OF URINARY INCONTINENCE |
WO2008134064A1 (en) * | 2007-04-28 | 2008-11-06 | The Board Of Trustees Of The Leland Stanford Junior University | Dynamic and adjustable support devices |
US20090004455A1 (en) * | 2007-06-27 | 2009-01-01 | Philippe Gravagna | Reinforced composite implant |
US20100049289A1 (en) | 2007-07-10 | 2010-02-25 | Ams Research Corporation | Tissue anchor |
US9427573B2 (en) | 2007-07-10 | 2016-08-30 | Astora Women's Health, Llc | Deployable electrode lead anchor |
CA2693198C (en) | 2007-07-27 | 2014-10-14 | Ams Research Corporation | Pelvic floor treatments and related tools and implants |
CA2695212C (en) | 2007-07-30 | 2017-11-28 | Boston Scientific Scimed, Inc. | Apparatus and method for the treatment of stress urinary incontinence |
AU2008287326A1 (en) * | 2007-08-14 | 2009-02-19 | Curant, Inc. | Devices for supporting, elevating, or compressing internal structures |
FR2919996B1 (en) * | 2007-08-17 | 2010-09-10 | Cl Medical | IMPLANT FOR SUPPORTING THE URETRE OF A MAN AND SURGICAL ASSEMBLY FOR TREATMENT OF URINARY INCONTINENCE IN A MAN COMPRISING SUCH AN IMPLANT |
US8465515B2 (en) * | 2007-08-29 | 2013-06-18 | Ethicon Endo-Surgery, Inc. | Tissue retractors |
US20090187066A1 (en) * | 2007-09-18 | 2009-07-23 | The Cleveland Clinic Foundation | Apparatus and method for treating urinary incontinence |
US8623034B2 (en) | 2007-10-19 | 2014-01-07 | Ethicon, Gmbh | Soft tissue repair implant |
US8206280B2 (en) | 2007-11-13 | 2012-06-26 | C. R. Bard, Inc. | Adjustable tissue support member |
US9308068B2 (en) | 2007-12-03 | 2016-04-12 | Sofradim Production | Implant for parastomal hernia |
US20090156891A1 (en) * | 2007-12-12 | 2009-06-18 | Ams Research Corporation | Prolapse and Perineal Repair Concepts |
US20090171141A1 (en) * | 2007-12-27 | 2009-07-02 | Chu Michael S H | Anterior Repair - Needle Path and Incision Sites |
US9282958B2 (en) | 2007-12-28 | 2016-03-15 | Boston Scientific Scimed, Inc. | Devices and method for treating pelvic dysfunctions |
JP5677850B2 (en) | 2007-12-28 | 2015-02-25 | シンセス ゲゼルシャフト ミット ベシュレンクテル ハフツングSynthes Gmbh | Combined body for impact driving into the patient's bone |
US9078728B2 (en) * | 2007-12-28 | 2015-07-14 | Boston Scientific Scimed, Inc. | Devices and methods for delivering female pelvic floor implants |
US8430807B2 (en) * | 2007-12-28 | 2013-04-30 | Boston Scientific Scimed, Inc. | Devices and methods for treating pelvic floor dysfunctions |
WO2009111802A1 (en) * | 2008-03-07 | 2009-09-11 | Alure Medical, Inc. | Minimally invasive tissue support |
US8323336B2 (en) | 2008-04-23 | 2012-12-04 | Medtronic, Inc. | Prosthetic heart valve devices and methods of valve replacement |
US20090287239A1 (en) * | 2008-05-16 | 2009-11-19 | Ams Research Corporation | Tissue Bulking Device and Method |
US9295757B2 (en) * | 2008-06-10 | 2016-03-29 | Cook Biotech Incorporated | Quilted implantable graft |
BRPI0914996B1 (en) | 2008-06-10 | 2018-10-30 | Cook Biotech Inc | surgical graft and method for manufacturing a surgical graft |
US9242026B2 (en) * | 2008-06-27 | 2016-01-26 | Sofradim Production | Biosynthetic implant for soft tissue repair |
US8727963B2 (en) | 2008-07-31 | 2014-05-20 | Ams Research Corporation | Methods and implants for treating urinary incontinence |
US9017243B2 (en) | 2008-08-25 | 2015-04-28 | Ams Research Corporation | Minimally invasive implant and method |
JP2012500712A (en) * | 2008-08-25 | 2012-01-12 | エーエムエス リサーチ コーポレイション | Implants and methods with minimal invasion |
US10278692B2 (en) | 2008-10-23 | 2019-05-07 | CMC Group LLC | Sling suspension system for supporting the thumb of a patient after basal joint arthroplasty |
US20100106254A1 (en) | 2008-10-23 | 2010-04-29 | Delsignore Jeanne L | Surgical implantable stabilizer sling for basal joint arthroplasty |
WO2010049368A1 (en) * | 2008-10-30 | 2010-05-06 | Compagnie De Recherche En Composants, Implants Et Materiels Pour L'application Clinique | Kit for supporting an organ including an elongate implantable member with a reinforcement means |
EP2352435B1 (en) | 2008-10-31 | 2019-11-27 | Sinclair Pharmaceuticals Limited | Minimally invasive tissue support system with a superior tissue support and an inferior anchor |
US8449573B2 (en) * | 2008-12-05 | 2013-05-28 | Boston Scientific Scimed, Inc. | Insertion device and method for delivery of a mesh carrier |
CA2747607C (en) * | 2009-01-05 | 2017-05-23 | Caldera Medical, Inc. | Implants and procedures for supporting anatomical structures for treating conditions such as pelvic organ prolapse |
ES1069756Y (en) * | 2009-02-03 | 2009-08-13 | Mugica Jose Manuel Devesa | DYNAMIC CLOSURE DEVICE FOR THE TREATMENT OF ANAL INCONTINENCE |
US9226809B2 (en) | 2009-02-10 | 2016-01-05 | Ams Research Corporation | Surgical articles and methods for treating urinary incontinence |
GB2467960A (en) * | 2009-02-23 | 2010-08-25 | Neosurgical Ltd | Laparoscopic surgical retraction device with expanding element and anchor arrangement |
US8556990B2 (en) * | 2009-02-23 | 2013-10-15 | Barry K. Bartee | Reinforced PTFE medical barriers |
US8251889B2 (en) * | 2009-02-25 | 2012-08-28 | Mis Solutions, Inc. | Apparatus and method for intra-abdominally moving a first internal organ to a position away from a second internal organ and then holding the first internal organ in the position without manual input |
US9539433B1 (en) | 2009-03-18 | 2017-01-10 | Astora Women's Health, Llc | Electrode implantation in a pelvic floor muscular structure |
US20110011407A1 (en) * | 2009-04-09 | 2011-01-20 | Minnesota Medical Development, Inc. | Apparatus and method for pelvic floor repair in the human female |
US20100261954A1 (en) * | 2009-04-09 | 2010-10-14 | Minnesota Medical Development, Inc. | Apparatus and Method for Pelvic Floor Repair in the Human Female |
US20100261953A1 (en) * | 2009-04-09 | 2010-10-14 | Minnesota Medical Development, Inc. | Apparatus and method for pelvic floor repair in the human female |
US20100261956A1 (en) * | 2009-04-09 | 2010-10-14 | Minnesota Medical Development, Inc. | Apparatus and Method for Pelvic Floor Repair in the Human Female |
US8968334B2 (en) | 2009-04-17 | 2015-03-03 | Boston Scientific Scimed, Inc. | Apparatus for delivering and anchoring implantable medical devices |
US9125716B2 (en) | 2009-04-17 | 2015-09-08 | Boston Scientific Scimed, Inc. | Delivery sleeve for pelvic floor implants |
US20100298629A1 (en) * | 2009-05-20 | 2010-11-25 | Huang Chih-Kun | Device and method for suspending an organ during surgery |
FR2949688B1 (en) | 2009-09-04 | 2012-08-24 | Sofradim Production | FABRIC WITH PICOTS COATED WITH A BIORESORBABLE MICROPOROUS LAYER |
US9301750B2 (en) * | 2009-11-03 | 2016-04-05 | Boston Scientific Scimed, Inc. | Device and method for delivery of mesh-based devices |
WO2011079222A2 (en) * | 2009-12-23 | 2011-06-30 | Boston Scientific Scimed, Inc. | Less traumatic method of delivery of mesh-based devices into human body |
US9364308B2 (en) | 2009-12-30 | 2016-06-14 | Astora Women's Health, Llc | Implant systems with tensioning feedback |
CN105877689A (en) | 2009-12-30 | 2016-08-24 | 阿斯托拉妇女保健有限责任公司 | Systems, implants, tools, and methods for treatments of pelvic conditions |
US8380312B2 (en) | 2009-12-31 | 2013-02-19 | Ams Research Corporation | Multi-zone stimulation implant system and method |
US9445881B2 (en) | 2010-02-23 | 2016-09-20 | Boston Scientific Scimed, Inc. | Surgical articles and methods |
EP4218668A1 (en) | 2010-02-23 | 2023-08-02 | Boston Scientific Scimed, Inc. | Surgical articles for treating incontinence |
US9987114B2 (en) | 2010-03-24 | 2018-06-05 | Covidien Lp | Combination three-dimensional surgical implant |
US20130053688A1 (en) | 2010-05-13 | 2013-02-28 | Ams Research Corporation | Implantable mechanical support |
US8550979B2 (en) | 2010-06-15 | 2013-10-08 | Coloplast A/S | Method of treating incontinence |
FR2962646B1 (en) | 2010-07-16 | 2012-06-22 | Sofradim Production | PROSTHETIC WITH RADIO OPAQUE ELEMENT |
US10028813B2 (en) | 2010-07-22 | 2018-07-24 | Boston Scientific Scimed, Inc. | Coated pelvic implant device and method |
US8911348B2 (en) | 2010-09-02 | 2014-12-16 | Boston Scientific Scimed, Inc. | Pelvic implants and methods of implanting the same |
WO2012050973A1 (en) | 2010-09-29 | 2012-04-19 | Ams Research Corporation | Systems, tools, and methods for treatments of pelvic conditions |
US9861590B2 (en) | 2010-10-19 | 2018-01-09 | Covidien Lp | Self-supporting films for delivery of therapeutic agents |
US9271754B2 (en) | 2010-12-16 | 2016-03-01 | Boston Scientific Scimed, Inc. | Movable curved needle for delivering implants and methods of delivering implants |
US9968428B2 (en) | 2010-12-16 | 2018-05-15 | Boston Scientific Scimed, Inc. | Surgical tools, systems, and related implants and methods |
US9572648B2 (en) | 2010-12-21 | 2017-02-21 | Justin M. Crank | Implantable slings and anchor systems |
US9381075B2 (en) | 2011-01-31 | 2016-07-05 | Boston Scientific Scimed, Inc. | Deflection member for delivering implants and methods of delivering implants |
ITMI20110124A1 (en) * | 2011-02-01 | 2012-08-02 | Innovamedica S P A | PELVIC SURGICAL REPAIR DEVICE AND KIT |
US9622848B2 (en) | 2011-02-23 | 2017-04-18 | Boston Scientific Scimed, Inc. | Urethral stent system and method |
US9125717B2 (en) | 2011-02-23 | 2015-09-08 | Ams Research Corporation | Implant tension adjustment system and method |
FR2972626B1 (en) | 2011-03-16 | 2014-04-11 | Sofradim Production | PROSTHETIC COMPRISING A THREE-DIMENSIONAL KNIT AND ADJUSTED |
US20120253108A1 (en) | 2011-03-28 | 2012-10-04 | Fischer Brian G | Implants, tools, and methods for treatment of pelvic conditions |
US10034735B2 (en) | 2011-03-28 | 2018-07-31 | Boston Scientific Scimed, Inc. | Implants, tools, and methods for treatments of pelvic conditions |
US8808162B2 (en) | 2011-03-28 | 2014-08-19 | Ams Research Corporation | Implants, tools, and methods for treatment of pelvic conditions |
EP2691045B1 (en) | 2011-03-30 | 2018-10-17 | Boston Scientific Scimed, Inc. | Pelvic implant |
US9492259B2 (en) | 2011-03-30 | 2016-11-15 | Astora Women's Health, Llc | Expandable implant system |
CA2839851C (en) | 2011-03-30 | 2018-05-22 | Ams Research Corporation | Implants, tools, and methods for treatment of pelvic conditions |
US9113991B2 (en) | 2011-05-12 | 2015-08-25 | Boston Scientific Scimed, Inc. | Anchors for bodily implants and methods for anchoring bodily implants into a patient's body |
US9636201B2 (en) | 2011-05-12 | 2017-05-02 | Boston Scientific Scimed, Inc. | Delivery members for delivering an implant into a body of a patient |
US9220887B2 (en) | 2011-06-09 | 2015-12-29 | Astora Women's Health LLC | Electrode lead including a deployable tissue anchor |
US10058240B2 (en) | 2011-06-29 | 2018-08-28 | Boston Scientific Scimed, Inc. | Systems, implants, tools, and methods for treatments of pelvic conditions |
US20130006049A1 (en) | 2011-06-30 | 2013-01-03 | Alexander James A | Implants, tools, and methods for treatments of pelvic conditions |
AU2012275175B2 (en) * | 2011-06-30 | 2016-12-15 | Boston Scientific Scimed, Inc. | Implants, tools, and methods for treatments of pelvic conditions |
US9351723B2 (en) | 2011-06-30 | 2016-05-31 | Astora Women's Health, Llc | Implants, tools, and methods for treatments of pelvic conditions |
EP2731507B1 (en) | 2011-07-11 | 2019-08-21 | Boston Scientific Scimed, Inc. | Implants and tools for treatments of pelvic conditions |
FR2977790B1 (en) | 2011-07-13 | 2013-07-19 | Sofradim Production | PROSTHETIC FOR UMBILIC HERNIA |
FR2977789B1 (en) | 2011-07-13 | 2013-07-19 | Sofradim Production | PROSTHETIC FOR UMBILIC HERNIA |
EP2731561B1 (en) * | 2011-07-14 | 2016-03-23 | Cook Medical Technologies LLC | A sling to be used in the treatment of obstructive sleep apnea |
US9414903B2 (en) | 2011-07-22 | 2016-08-16 | Astora Women's Health, Llc | Pelvic implant system and method |
EP2734148B1 (en) | 2011-07-22 | 2019-06-05 | Boston Scientific Scimed, Inc. | Pelvic implant system |
US8579924B2 (en) | 2011-07-26 | 2013-11-12 | Covidien Lp | Implantable devices including a mesh and a pivotable film |
GB201113303D0 (en) * | 2011-08-02 | 2011-09-14 | Xiros Ltd | Connective tissue repair pad |
WO2013020076A1 (en) | 2011-08-03 | 2013-02-07 | Ams Research Corporation | Systems, methods, and implants for treating prolapse or incontinence |
US9492191B2 (en) | 2011-08-04 | 2016-11-15 | Astora Women's Health, Llc | Tools and methods for treatment of pelvic conditions |
US20130035555A1 (en) | 2011-08-05 | 2013-02-07 | Alexander James A | Systems, implants, tools, and methods for treatment of pelvic conditions |
US9782957B2 (en) | 2011-08-24 | 2017-10-10 | Covidien Lp | Medical device films |
WO2013028145A1 (en) | 2011-08-25 | 2013-02-28 | Scott Stephen J | Apparatus and method for intra-abdominally moving a first internal organ to a position away from a second internal organ and then holding the first internal organ in the position without manual input |
US9402704B2 (en) | 2011-08-30 | 2016-08-02 | Boston Scientific Scimed, Inc. | Fecal incontinence treatment device and method |
US10098721B2 (en) | 2011-09-01 | 2018-10-16 | Boston Scientific Scimed, Inc. | Pelvic implant needle system and method |
US9345472B2 (en) | 2011-09-02 | 2016-05-24 | Boston Scientific Scimed, Inc. | Multi-arm tool for delivering implants and methods thereof |
USD736382S1 (en) | 2011-09-08 | 2015-08-11 | Ams Research Corporation | Surgical indicator with backers |
USD721807S1 (en) | 2011-09-08 | 2015-01-27 | Ams Research Corporation | Surgical indicators |
US9731112B2 (en) | 2011-09-08 | 2017-08-15 | Paul J. Gindele | Implantable electrode assembly |
USD721175S1 (en) | 2011-09-08 | 2015-01-13 | Ams Research Corporation | Backers for surgical indicators |
US9168120B2 (en) | 2011-09-09 | 2015-10-27 | Boston Scientific Scimed, Inc. | Medical device and methods of delivering the medical device |
CA2849052C (en) | 2011-09-30 | 2019-11-05 | Sofradim Production | Reversible stiffening of light weight mesh |
US9005308B2 (en) | 2011-10-25 | 2015-04-14 | Covidien Lp | Implantable film/mesh composite for passage of tissue therebetween |
US8932621B2 (en) | 2011-10-25 | 2015-01-13 | Covidien Lp | Implantable film/mesh composite |
US9179994B2 (en) | 2011-10-25 | 2015-11-10 | Covidien Lp | Implantable film/mesh composite |
FR2985170B1 (en) | 2011-12-29 | 2014-01-24 | Sofradim Production | PROSTHESIS FOR INGUINAL HERNIA |
FR2985271B1 (en) | 2011-12-29 | 2014-01-24 | Sofradim Production | KNITTED PICOTS |
CN104080416B (en) * | 2012-01-24 | 2017-10-17 | 新特斯有限责任公司 | Housing screw system |
EP3517145A1 (en) * | 2012-02-08 | 2019-07-31 | Boston Scientific Scimed, Inc. | Surgical scaffolds |
US10206769B2 (en) | 2012-03-30 | 2019-02-19 | Covidien Lp | Implantable devices including a film providing folding characteristics |
US9820837B2 (en) * | 2012-04-10 | 2017-11-21 | Ethicon, Inc. | Single plane tissue repair patch |
FR2992662B1 (en) | 2012-06-28 | 2014-08-08 | Sofradim Production | KNIT WITH PICOTS |
IN2015DN00690A (en) | 2012-06-29 | 2015-06-26 | Jeffrey Smith | |
FR2992547B1 (en) | 2012-06-29 | 2015-04-24 | Sofradim Production | PROSTHETIC FOR HERNIA |
US9649114B2 (en) | 2012-07-24 | 2017-05-16 | Ams Research Corporation | Systems, tools, and methods for connecting to tissue |
FR2994185B1 (en) | 2012-08-02 | 2015-07-31 | Sofradim Production | PROCESS FOR THE PREPARATION OF A POROUS CHITOSAN LAYER |
FR2995778B1 (en) | 2012-09-25 | 2015-06-26 | Sofradim Production | ABDOMINAL WALL REINFORCING PROSTHESIS AND METHOD FOR MANUFACTURING THE SAME |
FR2995788B1 (en) | 2012-09-25 | 2014-09-26 | Sofradim Production | HEMOSTATIC PATCH AND PREPARATION METHOD |
FR2995779B1 (en) | 2012-09-25 | 2015-09-25 | Sofradim Production | PROSTHETIC COMPRISING A TREILLIS AND A MEANS OF CONSOLIDATION |
US9750595B2 (en) | 2012-09-28 | 2017-09-05 | Covidien Lp | Implantable medical devices which include grip-members and methods of use thereof |
US10159555B2 (en) | 2012-09-28 | 2018-12-25 | Sofradim Production | Packaging for a hernia repair device |
WO2014059432A2 (en) | 2012-10-12 | 2014-04-17 | Mardil, Inc. | Cardiac treatment system and method |
US20150265388A1 (en) | 2012-10-22 | 2015-09-24 | Ams Research Corporation | System and method for treatment of anal and fecal incontinence |
US9241779B2 (en) | 2012-11-02 | 2016-01-26 | Coloplast A/S | Male incontinence treatment system |
US10111651B2 (en) | 2012-11-02 | 2018-10-30 | Coloplast A/S | System and method of anchoring support material to tissue |
CN103800096B (en) * | 2012-11-14 | 2016-12-21 | 深圳迈普再生医学科技有限公司 | Pelvic floor dysfunction disease reparation is with implanting fiber diaphragm, preparation method and the medical apparatus and instruments containing it |
EP2931176B1 (en) * | 2012-12-11 | 2019-03-27 | Innoventions Ltd | Medical sling |
GB201301784D0 (en) | 2013-02-01 | 2013-03-20 | Xiros Ltd | Connective tissue repair technology |
US20140243891A1 (en) * | 2013-02-25 | 2014-08-28 | Arthrex, Inc. | Tissue protector suture constructs |
US9814555B2 (en) | 2013-03-12 | 2017-11-14 | Boston Scientific Scimed, Inc. | Medical device for pelvic floor repair and method of delivering the medical device |
DE102013004486A1 (en) * | 2013-03-14 | 2014-09-18 | Johnson & Johnson Medical Gmbh | Surgical implant |
WO2014146023A2 (en) | 2013-03-15 | 2014-09-18 | Ams Research Corporation | Surgical implant system and method |
CA2905345A1 (en) | 2013-03-15 | 2014-09-25 | Ams Research Corporation | Systems, tools, and methods for connecting to tissue |
EP3747396B1 (en) * | 2013-05-03 | 2024-01-24 | James W. Cullison | Surgical implant |
FR3006581B1 (en) | 2013-06-07 | 2016-07-22 | Sofradim Production | PROSTHESIS BASED ON TEXTILE FOR LAPAROSCOPIC PATHWAY |
FR3006578B1 (en) | 2013-06-07 | 2015-05-29 | Sofradim Production | PROSTHESIS BASED ON TEXTILE FOR LAPAROSCOPIC PATHWAY |
US10343385B2 (en) | 2013-07-18 | 2019-07-09 | Boston Scientific Scimed, Inc. | Bodily implant |
CA2919504A1 (en) | 2013-08-01 | 2015-02-05 | Christine BRONIKOWSKI | Tissue adjustment implant |
US9480546B2 (en) | 2013-08-05 | 2016-11-01 | Coloplast A/S | Hysteropexy mesh apparatuses and methods |
US9408696B2 (en) * | 2013-09-29 | 2016-08-09 | Coloplast A/S | Method of treating peyronie's disease |
USD717954S1 (en) | 2013-10-14 | 2014-11-18 | Mardil, Inc. | Heart treatment device |
US9962251B2 (en) | 2013-10-17 | 2018-05-08 | Boston Scientific Scimed, Inc. | Devices and methods for delivering implants |
US9522000B2 (en) | 2013-11-08 | 2016-12-20 | Coloplast A/S | System and a method for surgical suture fixation |
US11484301B2 (en) | 2014-01-14 | 2022-11-01 | Simparo Inc. | Suture-locking washer for use with a bone anchor, and method for supporting the thumb of a patient after basal joint arthroplasty, and other novel orthopedic apparatus and other novel orthopedic procedures |
US20170021149A9 (en) * | 2014-05-02 | 2017-01-26 | National Institute Of Standards And Technology | Biological sampling platform and processes for making and using same |
RU2567329C1 (en) * | 2014-09-08 | 2015-11-10 | Ильнур Ирекович Мусин | Method for surgical management of stress-induced urinary incontinence in females of reproductive age with use of collost collagen material |
EP3000433B1 (en) | 2014-09-29 | 2022-09-21 | Sofradim Production | Device for introducing a prosthesis for hernia treatment into an incision and flexible textile based prosthesis |
EP3000432B1 (en) | 2014-09-29 | 2022-05-04 | Sofradim Production | Textile-based prosthesis for treatment of inguinal hernia |
EP3029189B1 (en) | 2014-12-05 | 2021-08-11 | Sofradim Production | Prosthetic porous knit, method of making same and hernia prosthesis |
EP3059255B1 (en) | 2015-02-17 | 2020-05-13 | Sofradim Production | Method for preparing a chitosan-based matrix comprising a fiber reinforcement member |
US10806556B2 (en) | 2015-04-23 | 2020-10-20 | Boston Scientific Scimed, Inc. | Implant sheath system having a release feature |
EP3085337B1 (en) | 2015-04-24 | 2022-09-14 | Sofradim Production | Prosthesis for supporting a breast structure |
EP3106185B1 (en) | 2015-06-19 | 2018-04-25 | Sofradim Production | Synthetic prosthesis comprising a knit and a non porous film and method for forming same |
US10105204B2 (en) | 2015-06-25 | 2018-10-23 | Boston Scientific Scimed, Inc. | Implants, tools, and methods for treatment of pelvic conditions |
CN104921842B (en) * | 2015-06-29 | 2016-09-28 | 苏州大学 | The implant system repaired at the bottom of mesh sheet and basin is repaired at the bottom of a kind of basin |
US10413635B2 (en) * | 2015-08-17 | 2019-09-17 | Vivex Biomedical, Inc. | Umbilical cord transplant product |
EP3195830B1 (en) | 2016-01-25 | 2020-11-18 | Sofradim Production | Prosthesis for hernia repair |
WO2018064446A1 (en) * | 2016-09-30 | 2018-04-05 | The Regents Of The University Of Michigan | A method and device for closing the urogenital hiatus in the absence of or damage to the pubovisceral muscle field |
EP3312325B1 (en) | 2016-10-21 | 2021-09-22 | Sofradim Production | Method for forming a mesh having a barbed suture attached thereto and the mesh thus obtained |
AU2017362497B2 (en) * | 2016-11-18 | 2022-07-28 | Ancora Heart, Inc. | Myocardial implant load sharing device and methods to promote LV function |
EP3398554A1 (en) | 2017-05-02 | 2018-11-07 | Sofradim Production | Prosthesis for inguinal hernia repair |
EP3644911A1 (en) | 2017-06-29 | 2020-05-06 | Cook Medical Technologies, LLC | Implantable medical devices for tissue repositioning |
WO2019079709A1 (en) | 2017-10-19 | 2019-04-25 | C.R.Bard, Inc. | Self-gripping hernia prosthesis |
US11166800B2 (en) * | 2018-04-12 | 2021-11-09 | Axogen Corporation | Tissue grafts with pre-made attachment points |
RU2686437C1 (en) * | 2018-07-18 | 2019-04-25 | федеральное государственное бюджетное образовательное учреждение высшего образования "Башкирский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Method for prevention of pelvic floor dysfunction by a biological feedback method using a vagiton pneumo vaginal training apparatus |
EP3653171A1 (en) | 2018-11-16 | 2020-05-20 | Sofradim Production | Implants suitable for soft tissue repair |
US11510766B2 (en) | 2019-02-14 | 2022-11-29 | Uromedica, Inc. | Method and apparatus for monitoring implantable device for urinary continence |
WO2021011659A1 (en) | 2019-07-15 | 2021-01-21 | Ancora Heart, Inc. | Devices and methods for tether cutting |
CN113397758A (en) * | 2021-07-13 | 2021-09-17 | 日照天一生物医疗科技有限公司 | Suspender for treating stress urinary incontinence |
Family Cites Families (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2671444A (en) * | 1951-12-08 | 1954-03-09 | Jr Benjamin F Pease | Nonmetallic mesh surgical insert for hernia repair |
US3054406A (en) * | 1958-10-17 | 1962-09-18 | Phillips Petroleum Co | Surgical mesh |
US3580313A (en) * | 1969-01-07 | 1971-05-25 | Mcknight Charles A | Surgical instrument |
US3705575A (en) * | 1969-09-26 | 1972-12-12 | Lynn Euryl Edwards | Incontinence device for female use |
US3744495A (en) * | 1970-01-02 | 1973-07-10 | M Johnson | Method of securing prolapsed vagina in cattle |
US3710592A (en) * | 1970-07-30 | 1973-01-16 | I Scow | Crocheting apparatus |
US4000743A (en) * | 1975-07-09 | 1977-01-04 | Kenneth Weaver | Uterine anteverter |
US4172458A (en) * | 1977-11-07 | 1979-10-30 | Pereyra Armand J | Surgical ligature carrier |
US4452245A (en) * | 1980-06-06 | 1984-06-05 | Usher Francis C | Surgical mesh and method |
US4400833A (en) * | 1981-06-10 | 1983-08-30 | Kurland Kenneth Z | Means and method of implanting bioprosthetics |
US4414967A (en) * | 1981-06-22 | 1983-11-15 | Minnesota Mining And Manufacturing Company | Internal fixation of bone, tendon, and ligaments |
US4409974A (en) * | 1981-06-29 | 1983-10-18 | Freedland Jeffrey A | Bone-fixating surgical implant device |
US4741330A (en) * | 1983-05-19 | 1988-05-03 | Hayhurst John O | Method and apparatus for anchoring and manipulating cartilage |
US4545374A (en) * | 1982-09-03 | 1985-10-08 | Jacobson Robert E | Method and instruments for performing a percutaneous lumbar diskectomy |
US4997434A (en) * | 1983-02-16 | 1991-03-05 | Seedhom Bahaa B | Prosthetic ligaments and instruments for use in the surgical replacement of ligaments |
US4672957A (en) * | 1983-10-04 | 1987-06-16 | South African Inventions Development Corporation | Surgical device |
US4549545A (en) * | 1984-03-05 | 1985-10-29 | Ethicon Inc. | Segmented polyurethane surgical buttressing pledgets |
US4633873A (en) * | 1984-04-26 | 1987-01-06 | American Cyanamid Company | Surgical repair mesh |
GB8611129D0 (en) * | 1986-05-07 | 1986-06-11 | Annis D | Prosthetic materials |
FR2604085B1 (en) * | 1986-09-19 | 1989-11-17 | Audion Michel | OSTEOSYNTHESIS PLATE FOR CONTAINING AND REDUCING COLLAPSE OF ORBITARY FLOORS |
US4854316A (en) * | 1986-10-03 | 1989-08-08 | Davis Emsley A | Apparatus and method for repairing and preventing para-stomal hernias |
US4872451A (en) * | 1987-02-02 | 1989-10-10 | Moore Robert R | Glenohumeral ligament repair |
US4873977A (en) * | 1987-02-11 | 1989-10-17 | Odis L. Avant | Stapling method and apparatus for vesicle-urethral re-anastomosis following retropubic prostatectomy and other tubular anastomosis |
US5026398A (en) * | 1988-07-01 | 1991-06-25 | The Minnesota Mining And Manufacturing Company | Abrasion resistant prosthetic device |
US5112344A (en) * | 1988-10-04 | 1992-05-12 | Petros Peter E | Surgical instrument and method of utilization of such |
US5012822A (en) * | 1988-10-11 | 1991-05-07 | Schwarz Gerald R | Method for controlling urinary incontinence |
US5013292A (en) * | 1989-02-24 | 1991-05-07 | R. Laborie Medical Corporation | Surgical correction of female urinary stress incontinence and kit therefor |
US4938760A (en) * | 1989-03-29 | 1990-07-03 | American Medical Systems, Inc. | Female suspension procedure |
FR2646343B1 (en) * | 1989-04-27 | 1991-12-20 | Gazielly Dominique | DEVICE FOR REINFORCING AND SUPPORTING THE HAIR OF THE ROTATORS OF AN INDIVIDUAL SHOULDER JOINT |
US5441508A (en) * | 1989-04-27 | 1995-08-15 | Gazielly; Dominique | Reinforcement and supporting device for the rotator cuff of a shoulder joint of a person |
US4973300A (en) * | 1989-09-22 | 1990-11-27 | Pioneering Technologies, Inc. | Cardiac sling for circumflex coronary artery surgery |
US5019032A (en) * | 1990-04-03 | 1991-05-28 | Robertson Jack R | Refined suspension procedure with implement for treating female stress incontinence |
US5064434A (en) * | 1990-04-04 | 1991-11-12 | Haber Terry M | Genitourinary implant |
US5252701A (en) * | 1990-07-06 | 1993-10-12 | American Cyanamid Company | Segmented absorbable copolymer |
US5256133A (en) * | 1990-09-05 | 1993-10-26 | Spitz Robert M | Device for correcting stress urinary incontinence |
US5122155A (en) * | 1990-10-11 | 1992-06-16 | Eberbach Mark A | Hernia repair apparatus and method of use |
US5149329A (en) * | 1990-12-12 | 1992-09-22 | Wayne State University | Surgical suture carrier and method for urinary bladder neck suspension |
GB9106174D0 (en) * | 1991-03-22 | 1991-05-08 | Cumming John | Staple applicator for use in the surgical treatment of female stress incontinence |
US5254133A (en) * | 1991-04-24 | 1993-10-19 | Seid Arnold S | Surgical implantation device and related method of use |
EP0520177B1 (en) * | 1991-05-24 | 1995-12-13 | Synthes AG, Chur | Resorbable tendon and bone augmentation device |
GB9111972D0 (en) * | 1991-06-04 | 1991-07-24 | Clinical Product Dev Ltd | Medical/surgical devices |
US5232648A (en) * | 1991-07-19 | 1993-08-03 | United States Surgical Corporation | Bioabsorbable melt spun fiber based on glycolide-containing copolymer |
US5290217A (en) * | 1991-10-10 | 1994-03-01 | Earl K. Sipes | Method and apparatus for hernia repair |
US5289963A (en) * | 1991-10-18 | 1994-03-01 | United States Surgical Corporation | Apparatus and method for applying surgical staples to attach an object to body tissue |
EP0545091B1 (en) * | 1991-11-05 | 1999-07-07 | The Children's Medical Center Corporation | Occluder for repair of cardiac and vascular defects |
US5258000A (en) * | 1991-11-25 | 1993-11-02 | Cook Incorporated | Tissue aperture repair device |
US5611515A (en) * | 1991-12-03 | 1997-03-18 | Boston Scientic Corporation | Bladder neck suspension procedure |
WO1993010715A2 (en) * | 1991-12-03 | 1993-06-10 | Vesitec Medical, Inc. | Surgical treatment of stress urinary incontinence |
US5147374A (en) * | 1991-12-05 | 1992-09-15 | Alfredo Fernandez | Prosthetic mesh patch for hernia repair |
AU3242693A (en) * | 1991-12-06 | 1993-06-28 | Kensey Nash Corporation | Pads, methods of making, and methods of use for wound dressing, surgical reinforcement and hemostasis promotion |
IT1265008B1 (en) * | 1992-07-15 | 1996-10-17 | Lopez Francisco Garcia | VAGINAL SELF-SUTURE DEVICE TO AVOID URINARY INCONTINENCE IN WOMEN |
US5362294A (en) * | 1992-09-25 | 1994-11-08 | Seitzinger Michael R | Sling for positioning internal organ during laparoscopic surgery and method of use |
JPH06114067A (en) * | 1992-09-30 | 1994-04-26 | Takiron Co Ltd | Binding button for medical suture |
US5337736A (en) * | 1992-09-30 | 1994-08-16 | Reddy Pratap K | Method of using a laparoscopic retractor |
US5972000A (en) * | 1992-11-13 | 1999-10-26 | Influence Medical Technologies, Ltd. | Non-linear anchor inserter device and bone anchors |
IL103737A (en) * | 1992-11-13 | 1997-02-18 | Technion Res & Dev Foundation | Stapler device particularly useful in medical suturing |
US5328077A (en) * | 1992-11-19 | 1994-07-12 | Lou Ek Seng | Method and apparatus for treating female urinary incontinence |
US5368602A (en) * | 1993-02-11 | 1994-11-29 | De La Torre; Roger A. | Surgical mesh with semi-rigid border members |
US5433996A (en) * | 1993-02-18 | 1995-07-18 | W. L. Gore & Associates, Inc. | Laminated patch tissue repair sheet material |
US5474543A (en) * | 1993-05-17 | 1995-12-12 | Mckay; Hunter A. | Single needle apparatus and method for performing retropublic urethropexy |
US5505735A (en) * | 1993-06-10 | 1996-04-09 | Mitek Surgical Products, Inc. | Surgical anchor and method for using the same |
US5437603A (en) * | 1993-09-14 | 1995-08-01 | C.R. Bard, Inc. | Apparatus and method for implanting prostheses within periurethral tissues |
US5527342A (en) * | 1993-12-14 | 1996-06-18 | Pietrzak; William S. | Method and apparatus for securing soft tissues, tendons and ligaments to bone |
EP0754064B1 (en) * | 1994-04-08 | 2003-05-28 | Atrix Laboratories, Inc. | An adjunctive polymer system for use with medical device |
US5681310A (en) * | 1994-07-20 | 1997-10-28 | Yuan; Hansen A. | Vertebral auxiliary fixation device having holding capability |
US5899909A (en) * | 1994-08-30 | 1999-05-04 | Medscand Medical Ab | Surgical instrument for treating female urinary incontinence |
SE506164C2 (en) * | 1995-10-09 | 1997-11-17 | Medscand Medical Ab | Instruments for the treatment of urinary incontinence in women |
SE503271C2 (en) * | 1994-08-30 | 1996-04-29 | Medscand Ab | Instruments for the treatment of urinary incontinence in women and methods for such treatment |
AU3683995A (en) * | 1994-09-28 | 1996-04-19 | Innovasive Devices, Inc. | Suture tensioning device |
US6042583A (en) * | 1995-06-14 | 2000-03-28 | Medworks Corporation | Bone anchor-insertion tool and surgical method employing same |
US5591163A (en) * | 1995-06-14 | 1997-01-07 | Incont, Inc. | Apparatus and method for laparoscopic urethropexy |
US5697931A (en) * | 1995-06-14 | 1997-12-16 | Incont, Inc. | Apparatus and method for laparoscopic urethopexy |
US5643288A (en) * | 1995-06-14 | 1997-07-01 | Incont, Inc. | Apparatus and method for laparoscopic urethropexy |
DE19544162C1 (en) * | 1995-11-17 | 1997-04-24 | Ethicon Gmbh | Implant for suspension of the bladder in urinary incontinence in women |
US5785640A (en) * | 1996-05-23 | 1998-07-28 | Kresch; Arnold J. | Method for treating female incontinence |
US5816258A (en) * | 1996-06-13 | 1998-10-06 | General Surgical Innovations, Inc. | Bladder neck suspension method |
DE69808614T2 (en) * | 1997-02-13 | 2003-06-18 | Boston Scient Ltd | STABILIZATION SLING FOR USE IN MINIMALLY INVASIVE PELVIC SURGERY |
US5922026A (en) * | 1997-05-01 | 1999-07-13 | Origin Medsystems, Inc. | Surgical method and prosthetic strip therefor |
-
1998
- 1998-02-13 DE DE69808614T patent/DE69808614T2/en not_active Expired - Lifetime
- 1998-02-13 WO PCT/US1998/003066 patent/WO1998035632A1/en active IP Right Grant
- 1998-02-13 EP EP98907504A patent/EP0983033B1/en not_active Expired - Lifetime
- 1998-02-13 CA CA002280814A patent/CA2280814A1/en not_active Abandoned
- 1998-02-13 US US09/023,398 patent/US6042534A/en not_active Expired - Lifetime
- 1998-02-13 JP JP53599698A patent/JP2001511685A/en active Pending
- 1998-02-13 AU AU63295/98A patent/AU6329598A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP0983033A1 (en) | 2000-03-08 |
WO1998035632A1 (en) | 1998-08-20 |
AU6329598A (en) | 1998-09-08 |
DE69808614T2 (en) | 2003-06-18 |
EP0983033A4 (en) | 2000-05-17 |
JP2001511685A (en) | 2001-08-14 |
US6042534A (en) | 2000-03-28 |
EP0983033B1 (en) | 2002-10-09 |
DE69808614D1 (en) | 2002-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0983033B1 (en) | Stabilization sling for use in minimally invasive pelvic surgery | |
US11833021B2 (en) | Transobturator methods for installing sling to treat incontinence, and related devices | |
US6197036B1 (en) | Pelvic floor reconstruction | |
US9549803B2 (en) | Medical slings | |
US6755781B2 (en) | Medical slings | |
US8303526B2 (en) | Medical slings | |
US8727962B2 (en) | Devices for minimally invasive pelvic surgery | |
US20080004490A1 (en) | Tension free pelvic floor repair | |
AU2002254157A1 (en) | Medical slings | |
CA2711722C (en) | Medical slings |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |